Top

Stephen F. Kry, Ph.D.

Department of Radiation Physics, Division of Radiation Oncology

About Dr. Stephen F. Kry

My long-term professional goal is to improve the safety and efficacy of radiotherapy treatment for cancer patients by improving the quality and consistency of such treatments. The proposed project works directly towards this goal by ensuring consistent and quality radiotherapy is delivered to patients enrolled in clinical trials. This will have immediate benefit to those specific patients on clinical trial, and will benefit all patients in the long-term by ensuring that clinical trials generate the optimal results. I am well suited to be a co-investigator on this grant because I have substantial experience in evaluating doses delivered in a radiotherapy setting. This includes clinical experience, working with a wide range of radiotherapy patients undergoing contemporary radiotherapy. It also includes research in patient dosimetry, patient setup, and institution credentialing for clinical trials. Through these experiences I have a solid understanding of radiotherapy as it is currently practiced, the limitations of current practice, and what is necessary to ensure consistent, quality, treatments.

Primary Appointment

Professor (with tenure), Department of Radiation Physics, Division of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas

Associate Professor, Department of Radiation Physics, The University of Texas M. D. Anderson Cancer Center, Houston, TX

Member, Department of Graduate School of Biomedical Sciences, The University of Texas Health Science Center at Houston, Houston, TX

Dual/Joint/Adjunct Appointment

Member, Department of Graduate School of Biomedical Sciences, The University of Texas Health Science Center at Houston, Houston, TX

Education & Training

Degree-Granting Education

2007	The University of Texas M. D. Anderson Cancer Center, Houston, Texas, US, Medical Physics, Ph.D
2003	The University of Texas M. D. Anderson Cancer Center, Houston, Texas, US, Medical Physics, M.S
1999	University of British Columbia, Vancouver, CA, Honours Physics, BS

Licenses & Certifications

2016	American Board of Medical Quality
2010	Medical Physicist License awarded by the Texas Medical Board
2010	American Board of Radiology, Therapeutic Radiological Physics

Experience & Service

Faculty Academic Appointments

Associate Professor, Department of Radiation Physics, The University of Texas M. D. Anderson Cancer Center, Houston, TX, 2016 - 2021

Assistant Professor, Department of Radiation Physics, The University of Texas M. D. Anderson Cancer Center, Houston, TX, 2010 - 2016

Instructor, Department of Radiation Physics, The University of Texas M. D. Anderson Cancer Center, Houston, TX, 2007 - 2010

Associate Member, Department of Graduate School of Biomedical Sciences, The University of Texas Health Science Center at Houston, Houston, TX, 2007 - 2010

Graduate Research Assistant, Department of Radiation Physics, The University of Texas M. D. Anderson Cancer Center, Houston, TX, 2000 - 2007

Teaching Assistant, University of British Columbia, Vancouver, 1999

Administrative Appointments/Responsibilities

Member, Department of Core Facility Oversight Board, The University of Texas MD Anderson Cancer Center, Houston, Texas, 2022 - Present

Director, Imaging and Radiation Oncology Core Houston Quality Assurance Center, Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, 2021 - Present

Director, MD Anderson Phantom Laboratory, Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, 2021 - Present

Director, MD Anderson Radiation Quality Assurance Laboratory, Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, 2021 - Present

Director, Accredited Dosimetry Calibration Laboratory, Department of Radiation Physics, The University of Texas MD Anderson Cancer Center, Houston, TX, 2018 - Present

Member, Faculty Senate Travel Affairs Committee, The University of Texas MD Anderson Cancer Center, Houston, TX, 2016 - Present

Co-Chair, Faculty Senate Clinical Affairs Committee, The University of Texas M. D. Anderson Cancer Center, Houston, TX, 2016

Associate Director, Department of Imaging and Radiation Oncology Core Houston Quality Assurance Center Department of Radiation Physics, The University of Texas M. D. Anderson Cancer Center, Houston, TX, 2016 - 2020

Member, Department of Imaging and Radiation Oncology Core Research Committee, American College of Radiation, American College of Radiation, Reston, VA,, Reston, VA, 2013 - Present

Faculty Senator, The University of Texas M. D. Anderson Cancer Center, Houston, TX, 2013 - 2016

Other Professional Positions

Consultant, Development of Peer Review Programs for Medical Radiation for the Kingdom of Saudi Arabia, International Atomic Energy Agency, Riyadh, 2025 - Present

Consultant, development of virtual audit methodologies for global oncology, International Atomic Energy Agency, United Nation, Vienna, 2024 - Present

Board of Directors, Member, American Association of Physicists in Medicine, 2023 - Present

Member, Streamlining Clinical Trials Implementation Committee, National Cancer Institute, 2023 - Present

Consultant, development for the National Radiological Regulatory Commission of the Kingdom of Saudi Arabia, Nuclear Radiological Regulatory Commission / International Atomic Energy Agency, Riyadh, 2023

Consultant, Plan-Class Specific Reference Dosimetry, International Atomic Energy Agency, Vienna, Austria, United Nations, 2023

Member, AAPM TG-362. Multi-lesion stereotactic radiosurgery, American Association of Physicists in Medicine, College Park, MD, 2020 - Present

Member, AAPM TG-359. FLASH (ultra high dose rate) radiation dosimetry, American Association of Physicists in Medicine, College Park, MD, 2020 - Present

Chair, AAPM TG-360, Performance validation of surrogate assessment systems in the context of medical physics applications, American Association of Physicists in Medicine, College Park, MD, 2020 - Present

Member, Quality Assurance Subcommittee, American Association of Physicists in Medicine, College Park, MD, 2020 - Present

Member, NCTN Leadership Management Committee, National Clinical Trials Network, National Cancer Institute, 2020 - Present

Member, Therapy Physics Committee, American Association of Physicists in Medicine, College Park, MD, 2019 - Present

Member, Radiation Dosimetry and Treatment Planning Subcommittee, American Association of Physicists in Medicine, College Park, MD, 2018 - Present

Chair, AAPM TG-319, Dosimetric standardization for radiobiological studies, American Association of Physicists in Medicine, College Park, MD, 2018 - Present

Member, Big Data Subcommittee, American Association of Physicists in Medicine, College Park, MD, 2018 - 2020

Member, Regulations and FDA compliance committee, American Society for Radiation Oncology, 2018 - 2019

Consultant, Pan-Class Specific Reference Dosimetry, International Atomic Energy Agency, Vienna, Austria, United Nations, 2018

Consultant, Dosimetry Audit Methodology for Advanced Radiotherapy, International Atomic Energy Agency, United Nations, Vienna Austria, 2017

Member, Equipment Donation Subcommittee, American Association of Physicists in Medicine, College Park, MD, 2017 - Present

Member, Work Group for the Veterinary Radiation Therapy Oncology Group, College Park, MD, 2017 - Present

Member, Radiation Therapy Working Group of NCORP, NCI/NIH, Rockville, MD, 2016 - Present

Consultant, Dosimetry Audit Methodology for Advanced Radiotherapy, International Atomic Energy Agency, United Nations, Vienna Austria, 2016

Examiner, Therapeutic Radiological Physics, American Board of Radiology, Tucson, AZ, 2016

Chair, Global Harmonization Group for Quality Assurance, Therapeutic Radiological Physics, Brussels, 2015 - 2017

Chair, AAPM Task Group 329, Absolute Dose Calibration: Dose to Water or Dose to Muscle, American Association of Physicists in Medicine, College Park, MD, 2015 - 2020

Consultant, Development of a Training Package for Medical Physics Audits in Radiotherapy, International Atomic Energy Agency, United Nations, Vienna, Austria, 2015

Question Writer, Therapeutic Radiological Physics, American Board of Radiology, College Park, 2014

Consultant, Dosimetry Audit Methodology for Advanced Radiotherapy, International Atomic Energy Agency, United Nations, Vienna, Austria, 2014

Consultant, Database of IAEA Quality Audit Results, International Atomic Energy Agency, United Nations, Vienna, Austria, 2014

Consultant, Dosimetry Audit Methodology for Advanced Radiotherapy, International Atomic Energy Agency, United Nations, Vienna, Austria, 2013

Consultant, Directory of Radiotherapy Centres, International Atomic Energy Agency, United Nations, Vienna, Austria, 2012

Member, TG-244: Minimum Practice Guideline, Commissioning and QA of TPS in External Beam Radiotherapy, American Association of Physicists in Medicine, College Park, MD, 2012 - 2014

Chair, Work group on Radiation Dosimetry, American Association of Physicists in Medicine, College Park, MD, 2012 - 2018

Member, TG-219: Independent Dose and MU Verification for IMRT Patient Specific Quality Assurance, American Association of Physicists in Medicine, College Park, MD, 2011 - Present

Member, Radiation Safety Subcommittee, American Associations of Physicists in Medicine, College Park, MD, 2011 - Present

Chair, TG-158: Measurements and Calculations of Out of Field Doses from External Beam Radiotherapy, American Association of Physicists in Medicine, College Park, MD, 2011 - 2016

Member, TG-203: Management of Radiotherapy Patients with Implanted Cardiac Pacemakers and Defibrillators, American Association of Physicists in Medicine, College Park, MD, 2010 - 2020

Member, Work Group on Radiation Dosimetry, American Association of Physicists in Medicine, College Park, MD, 2010 - 2018

Member, Radiation Detection & Treatment Planning subcommittee, American Association of Physicists in Medicine, College Park, MD, 2009 - 2018

Chair, TG-191: Recommendations on the Use of Luminescent Dosimeters, American Association of Physicists in Medicine, College Park, MD, 2009 - 2020

Member, TG-159: Ethics Curriculum for Medical Physics Graduate Education, American Association of Physicists in Medicine, College Park, MD, 2007 - 2010

Member, Education and Training of Medical Physicists Committee, American Association of Physicists in Medicine, College Park, MD, 2006 - 2009

Chair, Student Physicist Subcommittee, American Association of Physicists in Medicine, College Park, MD, 2006 - 2007

Associate Member, American Society for Therapeutic Radiology and Oncology, Arlington, VA, 2006 - Present

Member, Student Physicist Subcommittee, American Association of Physicists in Medicine, College Park, MD, 2006 - 2008

Consultant, Database structure and migration, International Atomic Energy Agency, United Nations, Vienna, 2004 - Present

Member, American Association of Physicists in Medicine, Alexandria, VA, 2000 - Present

Extramural Institutional Committee Activities

Member, Division of Radiation Oncology Recognition and Awards Program, The University of Texas MD Anderson Cancer Center, 2023 - Present

Member, Core Facility Oversight Board, The University of Texas MD Anderson Cancer Center, 2022 - Present

Member, IAEA official collaborative partner committee, The University of Texas MD Anderson Cancer Center, 2020

Member, Facilities planning COVID recovery group, The University of Texas MD Anderson Cancer Center, 2020

Member, Communications guidelines during COVID development group, The University of Texas MD Anderson Cancer Center, 2020

Member, Faculty Senate Travel Committee, The University of Texas MD Anderson Cancer Center, 2020 - Present

Member, Radiation Dosimetry and Treatment Planning Subcommittee, American Association of Physicists in Medicine (AAPM), 2018 - Present

Member, Medical Physics Candidacy Exam Committee, The University of Texas MD Anderson Cancer Center, 2016 - 2018

Member, M. D. Anderson Faculty Academic Review Committee, The University of Texas MD Anderson Cancer Center, 2015 - 2018

Chair, Graduate School of Biomedical Sciences, Curriculum Committee, The University of Texas MD Anderson Cancer Center, 2014 - 2015

Member, Graduate School of Biomedical Sciences, Executive Committee, The University of Texas MD Anderson Cancer Center, 2014 - 2016

Member, Medical Physics Ad Hoc Curriculum review committee, The University of Texas MD Anderson Cancer Center, 2014 - 2015

Member, Graduate School of Biomedical Sciences, Curriculum Committee, The University of Texas MD Anderson Cancer Center, 2012 - 2015

Member, Medical Physics Program Steering Committee, The University of Texas MD Anderson Cancer Center, 2007 - 2018

Editorial Activities

Associate Editor, Medical Physics, 2015 - Present

Guest Associate Editor, Medical Physics, 2010 - 2015

Associate Editor, Journal of Applied Clinical Medical Physics, 2008 - Present

Honors & Awards

2025 - Present	Best Medical Physics Paper. “A ratioerhtapy community data-driven approach to determine which complexity metrics best predict the impact of atypical TPS beam modeling on clinical dose calculation accuracy, Journal of Applied Clinical Medical Physics. Role: Senior Author
2025 - Present	Best Oral Presentation Award. “Expanding the reach and impact of dosimetry auditing through AI.”, International Conference on Advanced in Radiation Oncology (ICARO-4). International Atomic Energy Agency, Vienna, Austria
2021	Distinguished Associate Editor, Medical Physics
2021	Volunteer Service Award, American Board of Radiology
2020	Submission selected as Best in Physics (one of the overall top 5 submissions), American Association of Physicists in Medicine Annual Meeting
2018	"A new anthropomorphic pediatric spine phantom for proton therapy clinical trial credentialing" selected as cover art for International Journal of Particle Therapy Volume 4 Issue 4, International Journal of Particle Therapy; Role: Senior author
2018	Fellow, American Association of Physicist in Medicine
2016	Highest Commendation, Graduate School of Biomedical Sciences
2014	Featured Article of Interest, Institutional patient-specific IMRT QA does not predict unacceptable plan delivery, ESTRO; Role: First author
2012	Published article, Proportion of second cancers attributable to radiotherapy treatment in adults: a cohort study in the US SEER cancer registries, discussed in New York Times article, Limiting the Fallout of Cancer Treatment
2012	Best radiation measurements article, Ion recombination correction factors (Pion) for Varian TrueBeam high-dose-rate therapy beams, Journal of Applied Clinical Medical Physics; Role: First author
2011	Web Feature, The Clinical Impact of the couch top and rails on IMRT and Arc Therapy, Medical Physics; Role: Senior author
2011	Featured Paper, The Clinical Impact of the Couch Top and Rails on IMRT and Arc Therapy, Physics in Medicine and Biology
2010	Highlights collection, Out-of-Field Photon Dose following removal of the Flattening Filter from a Medical Accelerator, Physics in Medicine and Biology; Role: First author
2009	Highlights collection, Treatment vault shielding for a flattening filter free Medical Linear Accelerator, Physics in Medicine and Biology; Role: First author
2008	Best Paper Award for, Vault Shielding for a Flattening-Filter Free Clinic, Medical Applications Session at 11th ICRS-11/RPSD
2007	Andrew Sowell/Wade Huggins Scholarship for Cancer Research, University of Texas Health Science Center at Houston
2007	Sylvan Rodriguez, Cancer Answers Award Scholarship, University of Texas Health Science Center at Houston
2007	President's Research Scholarship, Graduate School of Biomedical Sciences
2005	National Finalist, A Monte Carlo Simulation of Dose Out-of-Field, American Association of Physicists in Medicine Young Investigators' Symposium
2005	First Place, Interdisciplinary Health Care Team Competition
2005	Third Place, A Reduction in Neutron Production Through the use of a Flattening Filter Free Accelerator, Southwest Chapter American Association of Physicists in Medicine Young Investigators' Symposium
2005	Rosalie B. Hite Fellowship for Cancer Research
2003	Aaron Blanchard Research Award in Medical Physics, M. D. Anderson Cancer Center
2002	Thomas F. Burke Award for Outstanding Leadership and Service, University of Texas Health Science Center at Houston
2002	National Finalist, Risk Assessment of Secondary Malignancies from IMRT Treatments, American Association of Physicists in Medicine Young Investigators' Symposium
2000	American Association of Physics in Medicine Fellowship for Graduate Studies in Medical Physics in Medicine
1999	UBC Deans Honor List Inductee
1999	Golden Key National Honor Society Inductee
1995	Alberta Teachers Association Scholarship
1995	Alexander Rutherford Scholarship, Province of Alberta
1995	Imperial Oil Higher Education Award
1995	Outstanding Student Initiative Entrance Scholarship, University of British Columbia

Professional Memberships

Global Harmonisation Group for Clinical Trial Radiotherapy QA

2015

Canadian Organization of Medical Physicists

2013 - Present

American Nuclear Society

2008 - 2011

UTHSC Houston Executive Council

2006

American Society for Therapeutic Radiology and Oncology

2006

UTHSC Houston InterFaculty Council

2006

UTHSC Houston Diversity Council

2006

UTHSC-Houston Student InterCouncil

2005 - 2006

University of Texas System Student Advisory Council

2005

UTHSC-Houston Student InterCouncil

2002 - 2006

UTHSC-Houston Student Activities Committee

2001 - 2003

South-West Chapter of American Association of Physicists in Medicine

2000 - Present

American Association of Physicists in Medicine

2000 - Present

Selected Presentations & Talks

Local Presentations

2021. Patient specific IMRT QA (invited) SAM presentation at the Ohio-Penn AAPM Chapter meeting. Conference. American Association of Physicists in Medicine, US.
2021. Resources for SWAAPM members (invited). Conference. American Association of Physicists in Medicine, US.
2021. Commissioning an OSLD/TLD in vivo dosimetry program (invited). Conference. American Association of Physicists in Medicine, US.
2020. IROC's learning from national and international trial QA. What's working and what isn't (invited). Conference. Global Academic Program, AU.
2020. Pitfalls of IMRT QA (invited). Conference. American Association of Physicists in Medicine, US.
2018. IMRT QA: are we wasting our time? (invited). Conference. Arizona AAPM chapter. Phoenix, AZ, US.
2018. Identifying and elucidating causes of errors in IMRT (invited). Conference. Southern California AAPM chapter. San Diego, CA, US.
2016. IMRT: making sure we're moving forward, not backwards (invited). Conference. Keynote presentation at the Radiation Cup regional meeting, Orange, AU.
2014. Peripheral dose and other errors in treatment planning system calculations (invited). Conference. Southern California AAPM chapter meeting. San Diego, CA, US.

National Presentations

2024. Assessing the risk of CIED malfunction from radiation. Conference. American Association of Physicists in Medicine. Los Angeles, CA, US.
2024. IROC credentialing for FLASH trials. Conference. American Association of Physicists in Medicine. Los Angeles, CA, US.
2024. TG-360: Validating IMRT QA system performance. Conference. Winter Institute of Medical Physics. Denver, Colorado, US.
2023. Enhancing radiotherapy through dosimetry audits. Conference. Conference of Radiation Control Program Directors. Houston, TX, US.
2022. Sensitivity of carbon RBE models to reference parameter variations. Conference. American Association of Physicists in Medicine. Washington, DC, US.
2022. An overview of the Imaging and Radiation Oncology Core, presented as an ABR MOC self-assessment module. Conference. Washington, DC, US.
2022. Managing implanted devices, presented as an ABR MOC self-assessment module. Conference. Association of Physicists in Medicine. Washington, DC, US.
2021. Report dose to medium in clinical trials; a consensus from the Global Harmonisation. Conference. European Society for Therapeutic Radiation Oncology (Virtual), US.
2021. A consensus report from the global harmonization group on clinical trials: report dose-to-medium. Conference. American Association of Physicists in Medicine (Virtual), US.
2021. Enhancing quality in radiotherapy through dosimetry audits (the IROC experience), US.
2020. Current IMRT QA: pros and cons, presented as an ABR MOC self-assessment module. Invited. American Association of Physicists in Medicine, US.
2020. How calibrations can help save lives, presented as an ABR MOC self-assessment module. Invited. American Association of Physicists in Medicine, US.
2019. Findings from IROC's beam output evaluations. Conference. American Society of Therapeutic Radiation Oncology. Chicago, IL, US.
2018. Independent recalculation outperforms traditional measurement-based IMRT QA methods in detecting unacceptable plans. Conference. American Association of Physicists in Medicine. Nashville, TN, US.
2018. Radiation risk to radiotherapy patients. Invited. American Nuclear Society. Santa Fe, NM, US.
2018. Flipped Learning in the Medical Physics Classroom. Invited. American Association of Physicists in Medicine. Nashville, TN, US.
2018. Dose to water vs. muscle: Rationale. Conference. European Society for Therapeutic Radiation Oncology, US.
2017. Causes of failures in dosimetry audits. Invited. European Society for Therapeutic Radiation Oncology. Glasgow.
2017. Assessing the risk of CIED malfunction from radiation. Invited. American Association of Physicists in Medicine. Denver, CO, US.
2017. An update on the dosimetric accuracy of different treatment planning system algorithms in the IROC lung phantom. Conference. American Association of Physicists in Medicine. Denver, CO, US.
2017. Ionization measurements: ion chambers and solid state devices. Invited. Radiotherapy Service Engineer's Association. Denver, CO, US.
2017. IROC-Houston's use of Mobuis3D to detect TPS calculation errors. Conference. Mobius Medical Systems. Denver, CO, US.
2017. Dose to water vs. muscle: rationale. Invited. American Association of Physicists in Medicine. Denver, CO, US.
2017. Why do institutions fail the IROC H&N phantom?. Conference. Winter Institute of Medical Physics, CO, US.
2016. Task Group 191: clinical use of luminescent dosimeters. Invited. Presented at the American Association of Physicists in Medicine National Meeting. Washington, DC, US.
2016. Revitalizing your medical physics classroom: some examples and thoughts from the trenches. Invited. Panel discussion at the American Association of Physics in Medicine National Meeting. Washington, DC, US.
2015. Common errors and deficiencies in radiation oncology practice. Conference. Presented at the National AAPM Annual Meeting. Anaheim, CA, US.
2015. Task Group-158: measurement and calculation of out-of-field doses from external beam radiation therapy. Invited. Presented at the American Association of Physicists in Medicine national meeting. Anaheim, CA, US.
2015. IROC Houston on-site audits and parameters that affect performance. Conference. Presented at the National AAPM Annual Meeting. Anaheim, CA, US.
2015. The clinical use of OSLD. Invited. Presented as an ABR MOC Self-Assessment Module (SAM) at the Spring Clinical AAPM meeting. St. Louis, MO, US.
2014. Uncertainty analysis for dose measurements using OSLD results nanoDots. Conference. Presented at the National AAPM Meeting. Austin, TX, US.
2014. Stop lecturing me! New methods for teaching medical physics. Conference. Presented at the National AAPM Annual Meeting. Austin, TX, US.
2014. Beyond auditing: what we have learned from phantom credentialing for clinical trials. Invited. Presented as an ABR MOC Self-Assessment Module (SAM) at the AAPM Spring Clinical Meeting, USA. Denver, CO, US.
2013. In-House IMRT QA versus external phantom audit results. Conference. Presented at the National AAPM Annual Meeting. Indianapolis, IN, US.
2013. Clinical aspects of flattening filter free linear accelerators. Invited. Presented as an ABR MOC Self-Assessment Module (SAM) at the American Association of Physicists in Medicine spring clinical meeting. Phoenix, AZ, US.
2013. The Radiological Physics Center’s standard dataset for small field size output factors. Invited. Presented at the Radiosurgery Society Meeting. Carlsbad, CA, US.
2013. Verification of dose calculations by the Radiological Physics Center. Invited. Presented at the Radiosurgery Society Meeting. Carlsbad, CA, US.
2012. Algorithms used in heterogeneous dose calculations show systematic differences as measured in the Radiological Physics Center's anthropomorphic thorax phantom used for RTOG credentialing. Conference. Presented at the ASTRO Annual Meeting. Boston, MA, US.
2012. Investigation of a commercial OSLD system for CT dosimetry. Conference. National AAPM Annual Meeting. Charlotte, NC, US.
2012. Radiation related second cancers. Invited. Presented as a Continuing Education Session. Charlotte, NC, US.
2012. Late effects of radiation therapy: second cancers. Invited. Presented as a Self-Assessment Module (SAM). Dallas, TX, US.
2012. Problems with heterogeneous dose calculations in the RPC's thorax phantom. Conference. Presented at the Winter Institute. Breckenridge, CO, US.
2011. Neutron induced electron failures. Conference. Winter Institute of Medical Physics. Breckenridge, CO, US.
2010. A reassessment of neutron dose equivalents from radiotherapy. Conference. Presented at the Winter Institute of Medical Physics. Frisco, CO, US.
2010. Neutron-induced electronic failures around a high-energy medical linear accelerator. Invited. American Nuclear Society, Radiation Protection and Shielding Topical Meeting. Las Vegas, NV, US.
2010. Out-of-field dose from radiotherapy: magnitude, evaluation, and impact. Invited. American Association of Physicists in Medicine Annual Meeting. Philadelphia, PA, US.
2008. Treatment vault shielding for a medical accelerator with or without the flattening filter. Invited. American Nuclear Society. Reno, NV, US.
2008. Dose outside the treatment volume following removal of the flattening filter. Conference. National AAPM Annual Meeting. Houston, TX, US.
2006. Prostate IMRT using unflattened beams. Conference. National ASTRO Annual Meeting. Philadelphia, PA, US.
2006. Uncertainty analysis of risk of secondary fatal malignancies from radiotherapy treatments including IMRT. Conference. National AAPM Annual Meeting. Orlando, FL, US.
2005. A reduction in neutron production through the use of a flattening filter free accelerator. Conference. National AAPM Annual. Seattle, WA, US.
2005. A Monte Carlo simulation of dose out of field. Conference. National AAPM Annual Meeting. Seattle, WA, US.
2003. Risk assessment of secondary malignancies from IMRT treatments. Conference. National AAPM Annual Meeting. San Diego, CA, US.

International Presentations

2025. Expanding the reach and impact of dosimetry auditing through AI. ICARO-4. Vienna, AT.
2025. Role of Dosimetry Audits and Quality Assurance in clinical trials. Biennial meeting of the IAEA Dosimetry Audit Network. Vienna, AT.
2025. International collaboration ensuring high-quality audits for better cancer outcomes. ICARO-4. Vienna, AT.
2025. Validation of PSQA systems employed in advanced radiotherapy treatment techniques. ICARO-4. Vienna, AT.
2025. Introduction for the Global Quality Assurance of Radiation Therapy Clinical Trials Harmonisation Group (GHG). ICARO-4. Vienna, AT.
2025. Quality and safety in radiotherapy, does quality matter in radiotherapy and the role of dosimetry audits. Biennial meeting of the IAEA Dosimetry Audit Network. Vienna, AT.
2025. Panelist: Coordinating international audits. Biennial meeting of the IAEA Dosimetry Audit Network. Vienna, AT.
2025. The impact of poor beam modelling parameters on clinical plans. European Society for Radiotherapy and Oncology (ESTRO) annual meeting. Vienna, AT.
2025. Setting the standard for dosimetry audits through international collaboration. Stakeholders meeting of the Australian Clinical Dosimetry Service. Melbourne, AU.
2025. Quality in Radiation Oncology. IAEA technical expert workshop on quality audits. Riyadh, SA.
2025. Tasks for medical physicists to maximize quality. IAEA technical expert workshop on quality audits. Riyadh, SA.
2025. Incidents, Accidents, and Quality. IAEA technical expert workshop on quality audits. Riyadh, SA.
2025. The use of Checklists to ensure quality. IAEA technical expert workshop on quality audits. Riyadh, SA.
2025. Audit methodologies for advanced radiotherapy. IAEA technical expert workshop on quality audits. Riyadh, SA.
2024. Head and neck SBRT QA: what to watch out for. Conference. Trans-Tasman Radiation Oncology Group annual meeting. Newcastle, AU.
2024. Balancing data collection burden for participating centres and comprehensive utilization of clinical trial data: an NCI perspective. (Keynote). Conference. Trans-Tasman Radiation Oncology Group annual meeting. Newcastle, AU.
2024. The power of data and data sharing. (Keynote). Conference. Trans-Tasman Radiation Oncology Group - Technical Research Workshop. Newcastle, AU.
2023. Are your radiotherapy dose calculations correct? The need for dosimetry audits. Conference. Society for Therapeutic Radiation Oncology dosimetry audit course. London, GB.
2023. Dosimetry audits with motion management. Conference. European Society for Therapeutic Radiation Oncology dosimetry audit course. London, GB.
2023. Passive Detectors: OSLD and TLD. Conference. European Society for Therapeutic Radiation Oncology dosimetry audit course. London, GB.
2023. Lessons learned from dosimetry audits and considerations for reporting results. Conference. European Society for Therapeutic Radiation Oncology dosimetry audit course. London, GB.
2023. External validation for novel technology. Conference. European Society for Therapeutic Radiation Oncology annual meeting. Vienna, AT.
2022. The value of measurement-based proton peer review. Conference. European Society for Therapeutic Radiation Oncology. Copenhagen, DK.
2019. Obstacles in implementing advanced radiotherapy as revealed through IROC's end-to-end phantom program. Conference. International Organization for Medical Physics. Santiago, CL.
2019. Updates and challenges in detector technology for radiotherapy audits. Invited. International Symposium on Standards, Application and Quality Assurance in Medical Radiation Dosimetry. Vienna, AT.
2019. Are your radiotherapy dose calculations correct?. Invited. International Symposium on Standards, Applications, and Quality Assurance in Medical Radiation Dosimetry. Vienna, AT.
2019. IMRT QA: comparing independent recalculation against measurement-based methods. Conference. European Society for Therapeutic Radiation Oncology. Brussels, BE.
2018. Measurement and calculation of x-ray and neutron doses outside the treatment volume. Invited. International Union for Physical and Engineering Sciences in Medicine. Prague, CZ.
2017. The critical importance of high-quality radiation therapy. Invited. International Conference on Advances in Radiation Oncology. Vienna, AT.
2017. Different treatment planning system algorithms show different accuracies in the IROC lung phantom: updated results. Conference. Canadian Organization of Medical Physicists. Ottawa, CA.
2017. Causes of irradiation failures of IROC Houston's IMRT credentialing phantom. Conference. European Society for Therapeutic Radiotherapy and Oncology. Vienna, AT.
2016. IMRT dose delivery in practice: what are we actually delivering?. Invited. Keynote presentation at the Engineering and Physical Science in Medicine Annual Meeting, AU.
2016. The importance of high quality radiotherapy. Invited. Keynote presentation the Engineering and Physical Science in Medicine Annual Meeting, AU.
2016. The 4 R's: responsibilities, roles and remaining relevant. Invited. Panel discussion at the Engineering and Physical Science in Medicine Annual Meeting, AU.
2016. The future of medical physics. Invited. Panel discussion at the Engineering and Physical Science in Medicine Annual Meeting, AU.
2016. Determining the dose outside the treatment field: basic assessment and applications to radiation epidemiology. Invited. Presented at the workshop on risk of secondary cancer following radiotherapy, SE.
2016. Common errors in dosimetry radiotherapy practice. Conference. European Society for Therapeutic Radiological and Oncology (ESTRO), IT.
2013. Errors and limitations in treatment planning calculations for radiation oncology. Invited. International Conference on the use of Computers in Radiation Therapy. Melbourne, AU.
2013. Detectors and phantoms for on-site audits: parameters and characteristics. Invited. Presented at the Technical meeting of the IAEA on Harmonizing Quality Audits in Radiotherapy. Vienna, AT.
2013. Detectors and phantoms for remote audits: parameters and characteristics. Invited. Presented at the Technical meeting of the IAEA on Harmonizing Quality Audits in Radiotherapy, AT.
2012. The Radiological Physics Center and quality assurance in radiotherapy. Invited. Presented at the MedPhys National Norwegian Medical Physics Conference. Kvitfjell, NO.
2012. Flattening filter free accelerators. Invited. Presented at the MedPhys National Norwegian Medical Physics Conference. Kvitfjell, NO.
2011. IMRT QA for head and neck radiotherapy. Invited. Presented in the Head and Neck Radiotherapy Symposium. Vancouver, CA.
2011. The impact of 6 MV non-reference photon energy spectra on OSLD response. Conference. National AAPM Meeting. Vancouver, CA.
2011. Monte Carlo applications in the quality assurance of clinical trials. Invited. International Workshop on recent advances in Monte Carlo techniques in radiation therapy. Montreal, CA.
2011. Against the motion (Pre-treatment assessment is an essential component of QA). Invited. ESTRO Anniversary Congress. London, England, GB.
2010. Low doses out-of-field in advanced radiotherapy. Invited. 16th Solid State Dosimetry Conference. Sydney, AU.
2009. Out of field doses from advanced radiotherapy techniques. Invited. 10th Biennial Conference on Physics and Radiation Technology. Maastricht, NL.
2008. Vault shielding for a flattening-filter free clinac. Conference. International Conference on Radiation Shielding/Radiation Protection Dosimetry. Pine Mountain, US.
2002. Secondary dose from IMRT treatments. Conference. National 2002 Annual Meeting. Montreal, CA.

Formal Peers

2024. Learning lessons in radiation oncology. Copenhagen, DK.
2024. The importance of keeping dosimetry standards ahead of clinical practice. Newcastle NSW, AU.
2022. Establishing dosimetric standards before it’s too late. Copenhagen, DK.
2018. Findings using Mobius QA: A comparison with traditional IMRT QA. Invited. Calgary, CA.
2017. IROC Phantom results: causes of failure and implications for practice. Invited. Calgary, CA.
2015. Neutrons in radiation oncology: measurement and implications. Invited. Montreal, CA.
2014. Radiation Therapy: The importance and challenge of getting the basics right. Invited. Calgary, CA.
2013. Flattening filter free linear accelerators,. Invited. Calgary, CA.
2010. Low doses in radiotherapy and associated risks. Invited. Melbourne, AU.

Less

Grant & Contract Support

Date:	2024 - 2025
Title:	New detector evaluation
Funding Source:	NIH/NCI
Role:	PI

Date:	2024 - 2025
Title:	Quantifying the variability of standard of care image acquisition in NCTN trials
Funding Source:	NIH/NCI
Role:	PI

Date:	2024 - 2028
Title:	Medical Physics Peer Review
Funding Source:	US Oncology
Role:	PI

Date:	2023 - 2025
Title:	Exploring carbon ion radiotherapy uncertainties
Funding Source:	RaySearch Laboratories
Role:	PI

Date:	2023 - 2025
Title:	Development of web tools for improving institutional engagement in NCTN radiotherapy trials
Funding Source:	NCTN
Role:	PI

Date:	2023 - 2024
Title:	Stereotactic radiosurgery credentialing for clinical trials through the Division of Cancer Prevention
Funding Source:	NIH/NCI
Role:	PI

Date:	2023 - 2023
Title:	Quality assurance support for the Experimental Therapeutic Cancer Trials Network
Funding Source:	NIH/NCI
Role:	PI

Date:	2023 - 2024
Title:	Division of Cancer Prevention supplement for the Imaging and Radiation Oncology Core
Funding Source:	NIH/NCI
Role:	PI
ID:	CA180803

Date:	2023 - 2028
Title:	Improving the dosimetric accuracy of radiation therapy and incorporating its impact into clinical trials
Funding Source:	NIH/NCI
Role:	PI

Date:	2023 - 2025
Title:	Development of a quality assurance program for trials investigating FLASH
Funding Source:	NIH/NCI
Role:	PI

Date:	2022 - 2027
Title:	Quality assurance support for Varian trial (name withheld due to NDA)
Funding Source:	Varian Medical Systems
Role:	PI

Date:	2022 - 2023
Title:	Quality assurance support for the Experimental Therapeutic Cancer Trials Network
Funding Source:	NIH/NCI
Role:	PI

Date:	2022 - 2027
Title:	Stereotactic heavy ions vs. protons vs. photon (SHIPP) for unfavorable intermediate risk prostate cancenter
Funding Source:	NIH/NCI
Role:	Co-PI

Date:	2021 - 2024
Title:	Veterans Health Administration national radiation oncology program
Funding Source:	radiation oncology services
Role:	PI
ID:	36C24518C0181

Date:	2021 - 2024
Title:	National Radiation Oncology Program - Radiation Oncology Services
Funding Source:	Veterans Administration
Role:	PI
ID:	36C24518C0181

Date:	2021 - 2024
Title:	Radiotherapy
Funding Source:	quality assurance support
Role:	PI
ID:	BGB-A317-A1217-301

Date:	2021 - 2022
Title:	Division of Cancer Prevention supplement for the Imaging and Radiation Oncology Core
Funding Source:	NIH/NCI
Role:	PI

Date:	2021 - 2022
Title:	Surveying credentialing needs for radiopharmaceutical therapy in ETCTN 10450
Funding Source:	NIH/NCI
Role:	PI

Date:	2020 - 2024
Title:	Verification services for lung and SRS treatment verification
Funding Source:	Varian Medical Systems
Role:	PI

Date:	2020 - 2023
Title:	Peer review service support for China
Funding Source:	ZITDTR
Role:	PI

Date:	2020 - 2021
Title:	MR guided radiotherapy of mediastinal lymphoma to assess intra-fraction and intra-breath hold uncertainties
Funding Source:	ViewRay Inc
Role:	PI

Date:	2020 - 2021
Title:	Developing a carbon ion dosimetry quality assurance program
Funding Source:	NIH/NCI
Role:	PI
ID:	CA180803

Date:	2020 - 2021
Title:	Developing a carbon ion dosimetry audit program
Funding Source:	NIH/NCI
Role:	PI
ID:	U24-CA180803

Date:	2019 - 2025
Title:	Imaging and Radiation Oncology Core (IROC) Group
Funding Source:	NIH/NCI
Role:	PI
ID:	CA180803

Date:	2019 - 2020
Title:	Characterization of passive dosimeters in carbon ion radiotherapy beams
Funding Source:	NIH/NCI
Role:	PI
ID:	CA180803

Date:	2019 - 2023
Title:	Medical Physics Peer Review
Funding Source:	US Oncology
Role:	PI

Date:	2018
Title:	Characterization of the NSRL beam line at Brookhaven National Labs
Funding Source:	NIH/NCI
Role:	Principal Investigator-MDACC
ID:	CA180803

Date:	2018 - 2019
Title:	Feasibility of a measurement-based program for quality assurance of RBE algorithms in carbon ion therapy
Funding Source:	NIH/NCI
Role:	PI
ID:	CA180803

Date:	2018 - 2021
Title:	Evaluation of benefit/risk ratios and optimization of mammography screening that account for enhanced carcinogenic effectiveness of low energy x-rays
Funding Source:	IIRAP
Role:	Co-I

Date:	2017 - 2019
Title:	Improving Dose Coverage of Tumor Periphery in Radiotherapy of Lung Cancer through the Use of Flattening Filter Free Beams
Funding Source:	NIH/NCI
Role:	Co-I
ID:	1R03CA211143-01

Date:	2017 - 2021
Title:	Correcting Dose Calculation Errors in Radiation Oncology
Funding Source:	NIH/NCI
Role:	PI
ID:	1 R01 CA214526-01

Date:	2017 - 2020
Title:	Improving radiation therapy outcomes through personalized optimization of radiation beam properties
Funding Source:	NCI
Role:	Co-PI
ID:	CA214526

Date:	2016 - 2017
Title:	Improving target coverage in radiotherapy of spinal tumors through the use of FFF beams
Funding Source:	Center for Radiation Oncology Research
Role:	Co-I

Date:	2015 - 2016
Title:	Metal Artifact Reduction in Radiation Oncology
Funding Source:	Mobius Medical Systems LLP
Role:	PI

Date:	2015 - 2017
Title:	Medical Physics Peer-Review
Funding Source:	US Oncology
Role:	PI

Date:	2014 - 2017
Title:	25% Impact of Contemporary Radiation Therapy on Second Breast Cancers in Pediatric Patients, PA-11-260
Funding Source:	NIH/NCI
Role:	Co-PI
ID:	R01

Date:	2014 - 2019
Title:	Imaging and Radiation Oncology Core (IROC) Group
Funding Source:	NIH/NCI
Role:	Co-I
ID:	CA180803

Date:	2013 - 2017
Title:	A Randomized Phase III Clinical Trial of Weekly versus Tri-weekly Cisplatin based Chemoradiation in Locally Advanced Cervical Cancer. Korean Gynecological Oncology Group
Funding Source:	Radiotherapy quality assurance for the TACO trial
Role:	PI
ID:	KIRAMS 50906

Date:	2012 - 2013
Title:	CT dosimetry with nanoDot OSLD
Funding Source:	Laundauer Inc
Role:	PI

Date:	2011 - 2014
Title:	Radiological Physics Center
Funding Source:	NIH/NCI
Role:	Co-I
ID:	CA10953

Date:	2011 - 2014
Title:	Late Effects Following Radiotherapy
Funding Source:	UT MD Anderson Cancer Center Start Up Funds
Role:	PI

Date:	2007 - 2008
Title:	Phantom Measurements and Validation of High-Dose DVS
Funding Source:	Sicel Technology
Role:	PI

Selected Publications

Peer-Reviewed Articles

Duan, L, Mehrens, H, Kry, SF, Leif, JL, Hernandez, N, Acuna Scafati, LB, Taylor, PA. Trends and Challenges. International Journal of Particle Therapy 19, 2026. e-Pub 2026. PMID: 41584861.
Taylor, PA, Mehrens, H, Glenn, MC, Brooks, FE, Scott, H, Duan, L, Meyers, T, Rojas, DC, Yang, M, Alvarez, PE, Leif, JL, Molineu, HA, Kry, SF. Reference dosimetry data and machine performance comparison for tomotherapy delivery systems audited by IROC. Journal of applied clinical medical physics 26(12), 2025. e-Pub 2025. PMID: 41253711.
Owens, CA, Ludmir, EB, Liu, Q, Qiu, W, Gupta, AC, Smith, SA, Rigaud, B, Brock, K, Bates, JE, Meyers, TG, Paulino, AC, Peterson, CB, Kry, SF, Teepen, JC, Ronckers, CM, Neglia, JP, Leisenring, W, Oeffinger, KC, Nathan, PC, Turcotte, LM, Hodgson, DC, Hudson, MM, Robison, LL, Moskowitz, CS, Armstrong, GT, Henderson, TO, Yasui, Y, Howell, RM. Colorectal-Specific Radiation Dose and Chemotherapy Risk for Subsequent Colorectal Malignancies in Childhood Cancer Survivors. Journal of Clinical Oncology 43(31):3403-3421, 2025. e-Pub 2025. PMID: 41032739.
Karimzad, K, Shah, SJ, Kry, SF, Peeler, CR, Pollard-Larkin, JM, Koduri, A, Chacon Portillo, M, Chauhan, S, Amatullah, A, Miller, C, Strang, A, Song, J, Mir Zaman Shah, K, Lopez, D, Wagner, D, Tsai, J, Vachhani, S, Thakar, DR, Iliescu, C, Durand, J, Dougherty, AH, Kantharia, BK, Deswal, A. Safety of Contemporary Radiation Therapy in Patients With Cardiac Implantable Electronic Devices. Journal of the American Heart Association 14(17), 2025. e-Pub 2025. PMID: 40847479.
Brooks F, Hussein M, Lye J, Nelson C, Mitsuhiro N, Glenn M, Diez P, Patel R, Shaw M, Patallo I, Barry M, Clark CH, Lehmann J, Kry SF. Developing reference plans for evaluating global clinical trials credentialing and PSQA systems. J Appl Clin Med Phys 26(7), 2025. PMID: 40439871.
Hartzell S, Taddei PJ, Guan F, Mirandola A, Taylor P, Ciocca M, Margo G, Peterson CB, Kry SF. Microdosimetric evaluation of a clinical carbon ion beam using a tissue-equivalent proportional counter. Phys Med Biol 70(14), 2025. PMID: 40602421.
Hartzell S, Guan F, Margo G, Taylor P, Peterson CB, Kry SF. Quantifying Sensitivity of Carbon RBE Models to Reference Parameter Variations. Radiat Res 204(2):113-126, 2025. PMID: 40451240.
Edward, SS, Pollard-Larkin, JM, Balter, PA, Howell, RM, Peterson, CB, Kry, SF. IROC phantoms accurately detect MLC delivery errors. Journal of applied clinical medical physics 26(5), 2025. e-Pub 2025. PMID: 39967029.
Taylor, PA, Mirandola, A, Ciocca, M, Hartzell, S, Magro, G, Alvarez, PE, Peterson, CB, Peeler, CR, Koay, EJ, Howell, RM, Kry, SF. Characterization of LiF TLD-100 in carbon ion beams for remote audits. Medical physics 52(3):1858-1866, 2025. e-Pub 2025. PMID: 39718203.
Brooks, FE, Glenn, MC, Hernandez, V, Saez, J, Pollard-Larkin, JM, Peterson, CB, Howell, RM, Nelson, CL, Clark, CH, Kry, SF. Is the Imaging Radiation Oncology Core Head and Neck Credentialing Phantom an Effective Surrogate for Different Anatomic Sites?. International Journal of Radiation Oncology Biology Physics 121(3):811-821, 2025. e-Pub 2025. PMID: 39362313.
Hartzell, S, Guan, F, Magro, G, Taylor, PA, Taddei, PJ, Peterson, CB, Kry, SF. Contribution of Nuclear Fragmentation to Dose and RBE in Carbon-Ion Radiotherapy. Radiation research 203(2):96-106, 2025. e-Pub 2025. PMID: 39862066.
O'Daniel, JC, Hernandez, V, Clark, CH, Esposito, M, Lehmann, J, Mcniven, A, Olaciregui-Ruiz, I, Kry, SF. Which failures do patient-specific quality assurance systems need to catch?. Medical physics 52(1):88-98, 2025. e-Pub 2025. PMID: 39466302.
Brooks F, Glenn M, Hernandez V, Saez J, Pollard-Larkin J, Peterson CB, Howell RM, Nelson C, Clark CH, Kry SF. Is the Imaging and Radiation Oncology Core head and neck credentialing phantom an effective surrogate for different anatomic sites?. Int J Radiat Oncol Biol Phys, 2024. PMID: 39362313.
Esposito, M, Baldoni, R, Bossuyt, E, Bresciani, S, Clark, CH, Jones, M, Kry, SF, Perry, J, van de Kamer, J, Verellen, D, Jornet, N. A commissioning protocol for portal imaging-based radiotherapy in vivo dosimetry systems. Physics and Imaging in Radiation Oncology 32, 2024. e-Pub 2024. PMID: 39624392.
Ashraf, MR, Melemenidis, S, Liu, K, Grilj, V, Jansen, J, Velasquez, B, Connell, L, Schulz, JB, Bailat, C, Libed, A, Manjappa, R, Dutt, S, Soto, L, Lau, B, Garza, A, Larsen, W, Skinner, L, Yu, AS, Surucu, M, Graves, E, Maxim, PG, Kry, SF, Vozenin, MC, Schueler, E, Loo, BW. Multi-Institutional Audit of FLASH and Conventional Dosimetry With a 3D Printed Anatomically Realistic Mouse Phantom. International Journal of Radiation Oncology Biology Physics 120(1):287-300, 2024. e-Pub 2024. PMID: 38493902.
Scott, H, Alvarez, PE, Howell, RM, Riegel, AC, Sun, R, Liu, K, Kry, SF. Chromatic bleaching and fractionation effects on optically stimulated luminescent dosimeter reuse. Medical physics 51(9):6378-6389, 2024. e-Pub 2024. PMID: 38852196.
Scott H, Alvarez P, Alvarez P, Riegel A, Sun R, Liu K, Kry SF. Chromatic bleaching and fractionation effects on optically stimulated luminescent dosimeter reuse, 2024. e-Pub 2024. PMID: 38852196.
Desai, V, Labby, Z, Culberson, W, DeWerd, LA, Kry, SF. Multi-institution single geometry plan complexity characteristics based on IROC phantoms. Medical physics 51(8):5693-5707, 2024. e-Pub 2024. PMID: 38669453.
Taylor, PA, Mirandola, A, Ciocca, M, Hartzell, S, Vai, A, Alvarez, PE, Howell, RM, Koay, EJ, Peeler, CR, Peterson, CB, Kry, SF. Radiological clinical equivalence for phantom materials in carbon ion therapy. Medical physics 51(7):5154-5158, 2024. e-Pub 2024. PMID: 38598230.
Taylor, PA, Hartzell, S, Mirandola, A, Ciocca, M, Magro, G, Alvarez, PE, Peterson, CB, Peeler, CR, Koay, EJ, Howell, RM, Kry, SF. OSLD nanoDot characterization for carbon radiotherapy dosimetry. Physics in medicine and biology 69(11), 2024. e-Pub 2024. PMID: 38663410.
Shen CJ, Kry SF, Buchsbaum JC, Milano MT, Inskip PD, Ulin K, Francis JH, Wilson MW, Whelan KF, Mayo CS, Olch AJ, Constine LS, Terezakis SA, Vogelius IR. Retinopathy, Optic Neuropathy, and Cataract in Childhood Cancer Survivors Treated With Radiation Therapy: A PENTEC Comprehensive Review. Int J Radiat Oncol Biol Phys 119(2):431-445, 2024. e-Pub 2024. PMID: 37565958.
Olch AJ, van Luijk P, Hua CH, Avanzo M, Howell RM, Yorke E, Aznar MC, Kry SF. Physics Considerations for Evaluation of Dose for Dose-Response Models of Pediatric Late Effects From Radiation Therapy. Int J Radiat Oncol Biol Phys 119(2):360-368, 2024. e-Pub 2024. PMID: 37003845.
Brooks, FD, Glenn, MC, Hernandez, V, Saez, J, Mehrens, H, Pollard-Larkin, JM, Howell, RM, Peterson, CB, Nelson, CL, Clark, CH, Kry, SF. A radiotherapy community data-driven approach to determine which complexity metrics best predict the impact of atypical TPS beam modeling on clinical dose calculation accuracy. Journal of applied clinical medical physics 25(5), 2024. e-Pub 2024. PMID: 38427776.
Burton, A, Gaudreault, M, Hardcastle, N, Lye, J, Beveridge, S, Kry, SF, Franich, R. Optimized scoring of end-to-end dosimetry audits for passive motion management – A simulation study using the IROC thorax phantom. Physica Medica 121, 2024. e-Pub 2024. PMID: 38653119.
Scott, H, Alvarez, PE, Howell, RM, Riegel, AC, Sun, R, Kry, SF. Lifetime extension of optically stimulated luminescent dosimeters above 10 GY. Radiation Measurements 171, 2024. e-Pub 2024.
Nealon KA, Han EY, Kry SF, Nguyen C, Pham M, Reed VK, Rosenthal D, Simiele S, Court LE. Monitoring Variations in the Use of Automated Contouring Software. Pract Radiat Oncol 14(1):e75-e85, 2024. e-Pub 2024. PMID: 37797883.
Milgrom S, Dandapani S, Wong J, Kalapurakal J, Smith K, Han C, Simiele E, Hua C, Fitzgerald TJ, Kry SF, Wong K, Symons H, Kovalchuk N, Hiniker S. Incorporating intensity modulated total body irradiation into a Children’s Oncology Group trial: rationale, techniques and safeguards. Pediatric Blood Cancer. Pediatric Blood and Cancer 71(11):e31185, 2024. e-Pub 2024. PMID: 39118225.
Nealon KA, Douglas RJ, Han EY, Kry SF, Reed VK, Simiele SJ, Court LE. Hazard testing to reduce risk in the development of automated planning tools. J Appl Clin Med Phys 24(8):e13995, 2023. e-Pub 2023. PMID: 37073484.
Nakamura, M, Zhou, D, Minemura, T, Kito, S, Okamoto, H, Tohyama, N, Kurooka, M, Kumazaki, Y, Ishikawa, M, Clark, CH, Miles, E, Lehmann, J, Andratschke, N, Kry, SF, Ishikura, S, Mizowaki, T, Nishio, T. A virtual audit system for intensity-modulated radiation therapy credentialing in Japan Clinical Oncology Group clinical trials. Journal of applied clinical medical physics 24(6), 2023. e-Pub 2023. PMID: 37191875.
Mehrens H, Molineu A, Hernandez N, Court L, Howell R, Jaffray D, Peterson CB, Pollard-Larkin J, Kry SF. Characterizing the interplay of treatment parameters and complexity and their impact on performance on an IROC IMRT phantom using machine learning. Radiother Oncol 182:109577, 2023. e-Pub 2023. PMID: 36841341.
Taylor PA, Miles E, Hoffmann L, Kelly SM, Kry SF, Sloth Møller D, Palmans H, Akbarov K, Aznar MC, Clementel E, Corning C, Effeney R, Healy B, Moore A, Nakamura M, Patel S, Shaw M, Stock M, Lehmann J, Clark CH. Prioritizing clinical trial quality assurance for photons and protons: A failure modes and effects analysis (FMEA) comparison. Radiother Oncol 182:109494, 2023. e-Pub 2023. PMID: 36708923.
Ferrone, KL, Willis, CE, Guan, F, Ma, J, Peterson, L, Kry, SF. A Review of Magnetic Shielding Technology for Space Radiation. Radiation 3(1):46-57, 2023. e-Pub 2023.
Ferrone, KL, Willis, CE, Guan, F, Ma, J, Peterson, L, Kry, SF. Evaluating bone marrow dosimetry with the addition of bone marrow structures to the medical internal radiation dose phantom. Precision Radiation Oncology 7(1):27-35, 2023. e-Pub 2023. PMID: 40336618.
Owens CA, Rigaud B, Ludmir EB, Gupta AC, Shrestha S, Paulino AC, Smith SA, Peterson CB, Kry SF, Lee C, Henderson TO, Armstrong GT, Brock KK, Howell RM. Development and validation of a population-based anatomical colorectal model for radiation dosimetry in late effects studies of survivors of childhood cancer. Radiother Oncol 176:118-126, 2022. e-Pub 2022. PMID: 36063983.
Rhee DJ, Jhingran A, Huang K, Netherton TJ, Fakie N, White I, Sherriff A, Cardenas CE, Zhang L, Prajapati S, Kry SF, Beadle BM, Shaw W, O'Reilly F, Parkes J, Burger H, Trauernicht C, Simonds H, Court LE. Clinical acceptability of fully automated external beam radiotherapy for cervical cancer with three different beam delivery techniques. Med Phys 49(9):5742-5751, 2022. e-Pub 2022. PMID: 35866442.
Geurts MW, Jacqmin DJ, Jones LE, Kry SF, Mihailidis DN, Ohrt JD, Ritter T, Smilowitz JB, Wingreen NE. AAPM MEDICAL PHYSICS PRACTICE GUIDELINE 5.b: Commissioning and QA of treatment planning dose calculations-Megavoltage photon and electron beams. J Appl Clin Med Phys 23(9):e13641, 2022. e-Pub 2022. PMID: 35950259.
Rhee DJ, Akinfenwa CPA, Rigaud B, Jhingran A, Cardenas CE, Zhang L, Prajapati S, Kry SF, Brock KK, Beadle BM, Shaw W, O'Reilly F, Parkes J, Burger H, Fakie N, Trauernicht C, Simonds H, Court LE. Automatic contouring QA method using a deep learning-based autocontouring system. J Appl Clin Med Phys 23(8):e13647, 2022. e-Pub 2022. PMID: 35580067.
Zhu TC, Stathakis S, Clark JR, Feng W, Georg D, Holmes SM, Kry SF, Charlie Ma CM, Miften M, Mihailidis D, Moran JM, Papanikolaou N, Poppe B, Xiao Y. Erratum: "Report of AAPM Task Group 219 on independent calculation-based dose/MU verification for IMRT". Med Phys 49(8):5713, 2022. e-Pub 2022. PMID: 35833598.
Taylor PA, Lowenstein J, Followill D, Kry SF. The value of on-site proton audits. Int J Radiat Oncol Biol Phys 112(4):1004-1011, 2022. e-Pub 2022. PMID: 34780973.
Mahuvana C, Esplen N, Pourrier Y, Kry SF, Bazalova-Carter M. Monte Carlo dose calculations for radiobiology studies. Med Phys 49(3):1911-1923, 2022. e-Pub 2022. PMID: 35066889.
Mahuvava C, Esplen NM, Poirier Y, Kry SF, Bazalova-Carter M. Dose calculations for preclinical radiobiology experiments conducted with single-field cabinet irradiators. Med Phys 49(3):1911-1923, 2022. e-Pub 2022. PMID: 35066889.
Gupta AC, Owens CA, Shrestha S, Lee C, Smith SA, Weathers RE, Netherton T, Balter PA, Kry SF, Followill DS, Griffin KT, Long JP, Armstrong GT, Howell RM. Body region-specific 3D age-scaling functions for scaling whole-body computed tomography anatomy for pediatric late effects studies. Biomed Phys Eng Express 8(2), 2022. e-Pub 2022. PMID: 34874300.
Glenn MC, Brooks F, Peterson CB, Howell RM, Followill DS, Pollard-Larkin JM, Kry SF. Photon beam modeling variations predict errors in IMRT dosimetry audits. Radiother Oncol 166:8-14, 2022. e-Pub 2022. PMID: 34748857.
Mehrens H, Nguyen T, Edward S, Hartzell S, Glenn M, Branco D, Hernandez N, Alvarez P, Molineu A, Taylor P, Kry S. The current status and shortcomings of stereotactic radiosurgery. Neurooncol Adv 4(1):vdac058, 2022. e-Pub 2022. PMID: 35664554.
Tyagi N, Subashi E, Michael Lovelock D, Kry S, Alvarez PE, Hunt MA, Lim SB. Dosimetric evaluation of irradiation geometry and potential air gaps in an acrylic miniphantom used for external audit of absolute dose calibration for a hybrid 1.5 T MR-linac system. J Appl Clin Med Phys 23(2), 2022. e-Pub 2021. PMID: 34914175.
Corrigan KL, Kry S, Howell RM, Kouzy R, Jaoude JA, Patel RR, Jhingran A, Taniguchi C, Koong AC, McAleer MF, Nitsch P, Rödel C, Fokas E, Minsky BD, Das P, Fuller CD, Ludmir EB. The radiotherapy quality assurance gap among phase III cancer clinical trials. Radiother Oncol 166:51-57, 2022. e-Pub 2021. PMID: 34838891.
Shrestha S, Bates JE, Liu Q, Smith SA, Oeffinger KC, Chow EJ, Gupta AC, Owens CA, Constine LS, Hoppe BS, Leisenring WM, Qiao Y, Weathers RE, Court LE, Pinnix CC, Kry SF, Mulrooney DA, Armstrong GT, Yasui Y, Howell RM. Radiation therapy related cardiac disease risk in childhood cancer survivors: Updated dosimetry analysis from the Childhood Cancer Survivor Study. Radiother Oncol 163:199-208, 2021. e-Pub 2021. PMID: 34454975.
Ferrone, KL, Guan, F, Ma, J, Peterson, L, Willis, CE, Kry, SF. Reducing space radiation cancer risk with magnetic shielding. Advances in Space Research 68(1):153-160, 2021. e-Pub 2021.
Hartzell S, Guan F, Taylor P, Peterson C, Taddei P, Kry S. Uncertainty in tissue equivalent proportional counter assessments of microdosimetry and RBE estimates in carbon radiotherapy. Phys Med Biol 66(15), 2021. e-Pub 2021. PMID: 34252894.
FitzGerald TJ, Followill D, Laurie F, Boterberg T, Hanusik R, Kessel S, Karolczuk K, Iandoli M, Ulin K, Morano K, Bishop-Jodoin M, Kry S, Lowenstein J, Molineu A, Moni J, Cicchetti MG, Prior F, Saltz J, Sharma A, Mandeville H, Bernier-Chastagner V, Janssens G. Quality assurance in radiation oncology. Pediatric Blood & Cancer 68(S2):e, 2021. e-Pub 2021.
Branco D, Kry S, Taylor P, Zhang X, Rong J, Frank S, Followill D. Dosimetric impact of commercial CT metal artifact reduction algorithms and a novel in-house algorithm for proton therapy of head and neck cancer. Med Phys 48(1):445-455, 2021. e-Pub 2021. PMID: 33176003.
Branco D, Kry S, Taylor P, Rong J, Zhang X, Frank S, Followill D. Evaluation of image quality of a novel computed tomography metal artifact management technique on an anthropomorphic head and neck phantom. Phys Imaging Radiat Oncol 17:111-116, 2021. e-Pub 2021. PMID: 33898789.
Gupta AC, Shrestha S, Owens CA, Smith SA, Qiao Y, Weathers RE, Balter PA, Kry SF, Howell RM. Development of an age-scalable 3D computational phantom in DICOM standard for late effects studies of childhood cancer survivors. Biomed Phys Eng Express 6(6), 2020. e-Pub 2020. PMID: 34584772.
Shrestha S, Gupta AC, Bates JE, Lee C, Owens CA, Hoppe BS, Constine LS, Smith SA, Qiao Y, Weathers RE, Yasui Y, Court LE, Paulino AC, Pinnix CC, Kry SF, Followill DS, Armstrong GT, Howell RM. Development and validation of an age-scalable cardiac model with substructures for dosimetry in late-effects studies of childhood cancer survivors. Radiother Oncol. e-Pub 2020. PMID: 33075392.
Rhee DJ, Jhingran A, Rigaud B, Netherton T, Cardenas CE, Zhang L, Vedam S, Kry S, Brock KK, Shaw W, O'Reilly F, Parkes J, Burger H, Fakie N, Trauernicht C, Simonds H, Court LE. Automatic contouring system for cervical cancer using convolutional neural networks. Med Phys. e-Pub 2020. PMID: 32964477.
Glenn MC, Peterson CB, Howell RM, Followill DS, Pollard-Larkin JM, Kry SF. Sensitivity of IROC phantom performance to radiotherapy treatment planning system beam modeling parameters based on community-driven data. Med Phys:5250-5259, 2020. e-Pub 2020.
Branco D, Kry S, Taylor P, Rong J, Zhang X, Peterson C, Frank S, Followill D. Development of a stereoscopic CT metal artifact management algorithm using gantry angle tilts for head and neck patients. J Appl Clin Med Phys. e-Pub 2020. PMID: 32506820.
Mir R, Kelly SM, Xiao Y, Moore A, Clark CH, Clementel E, Corning C, Ebert M, Hoskin P, Hurkmans CW, Ishikura S, Kristensen I, Kry SF, Lehmann J, Michalski JM, Monti AF, Nakamura M, Thompson K, Yang H, Zubizarreta E, Andratschke N, Miles E. Organ at risk delineation for radiation therapy clinical trials: Global Harmonization Group consensus guidelines. Radiother Oncol. e-Pub 2020. PMID: 32504762.
Edward SS, Alvarez PE, Taylor PA, Molineu HA, Peterson CB, Followill DS, Kry SF. Differences in the patterns of failure between IROC lung and spine phantom irradiations. Pract Radiat Oncol. e-Pub 2020. PMID: 32413413.
Edward SS, Glenn M, Peterson CB, Balter PA, Pollard-Larkin JM, Howell RM, Followill D, Kry SF. Dose calculation errors as a component of failing IROC lung and spine phantom irradiations. Med Phys. e-Pub 2020. PMID: 32452027.
Meyer T, Quirk S, Husain S, Hilts M, Crook J, Watt E, Guebert A, Frederick A, Batchelar D, Kry SF, Roumeliotis M. Peer-based credentialing for brachytherapy: Application in permanent seed implant. Brachytherapy. e-Pub 2020. PMID: 32402545.
Mehrens H, Taylor P, Followill DS, Kry SF. Survey results of 3D-CRT and IMRT quality assurance practice. J Appl Clin Med Phys. e-Pub 2020. PMID: 32351006.
Gronberg MP, Tailor RC, Smith SA, Kry SF, Followill DS, Stojadinovic S, Niedzielski JS, Lindsay PE, Krishnan S, Aguirre F, Fujimoto TN, Taniguchi CM, Howell RM. A mail audit independent peer review system for dosimetry verification of a small animal irradiator. Radiat Res 193(4):341-350, 2020. e-Pub 2020. PMID: 32068498.
Kry SF, Alvarez P, Cygler JE, DeWerd LA, Howell RM, Meeks S, O'Daniel J, Reft C, Sawakuchi G, Yukihara EG, Mihailidis D. AAPM TG 191: Clinical use of luminescent dosimeters: TLDs and OSLDs. Med Phys 47(2):e19-e51, 2020. e-Pub 2020. PMID: 31574174.
Glenn MC, Peterson CB, Followill DS, Howell RM, Pollard-Larkin JM, Kry SF. Reference dataset of users' photon beam modeling parameters for the Eclipse, Pinnacle, and RayStation treatment planning systems. Med Phys 47(1):282-288, 2020. e-Pub 2020. PMID: 31667870.
Lye J, Kry S, Shaw M, Gibbons F, Keehan S, Lehmann J, Kron T, Followill D, Williams I. A comparison of IROC and ACDS on-site audits of reference and non-reference dosimetry. Med Phys 46(12):5878-5887, 2019. e-Pub 2019. PMID: 31494941.
Kry SF, Feygelman V, Balter P, Knöös T, Charlie Ma CM, Snyder M, Tonner B, Vassiliev ON. APM Task Group 329: Reference dose specification for dose calculations: Dose-to-water or dose-to-muscle?. Med Phys. e-Pub 2019. PMID: 31883390.
Miften M, Mihailidis D, Kry SF, Reft C, Esquivel C, Farr J, Followill D, Hurkmans C, Liu A, Gayou O, Gossman M, Mahesh M, Popple R, Prisciandaro J, Wilkinson J. Management of radiotherapy patients with implanted cardiac pacemakers and defibrillators: A Report of the AAPM TG-203†. Med Phys 46(12):e757-e788, 2019. e-Pub 2019. PMID: 31571229.
Wesolowska P, Georg D, Lechner W, Kazantsev P, Bokulic T, Tedgren AC, Adolfsson E, Campos AM, Alves VGL, Suming L, Hao W, Ekendahl D, Koniarova I, Bulski W, Chelminski K, Samper JLA, Vinatha SP, Rakshit S, Siri S, Tomsejm M, Tenhunen M, Povall J, Kry SF, Followill DS, Thwaites DI, Izewska J. Testing the methodology for a dosimetric end-to-end audit of IMRT/VMAT: results of IAEA multicentre and national studies. Acta Oncol 58(12):1731-1739, 2019. e-Pub 2019. PMID: 31423867.
Howell RM, Smith SA, Weathers RE, Kry SF, Stovall M. Adaptations to a generalized radiation dose reconstruction methodology for use in epidemiologic studies: an update from the MD Anderson late effect group. Radiat Res 192(2):169-188, 2019. e-Pub 2019. PMID: 31211642.
Kry SF, Glenn MC, Peterson CB, Branco D, Mehrens H, Steinmann A, Followill DS. Independent recalculation outperforms traditional measurement-based IMRT QA methods in detecting unacceptable plans. Med Phys. e-Pub 2019. PMID: 31152568.
Baltz GC, Chi PM, Wong PF, Wang C, Craft DF, Kry SF, Lin SSH, Garden AS, Smith SA, Howell RM. Development and validation of a 3D-printed bolus cap for total scalp irradiation. J Appl Clin Med Phys 20(3):89-96, 2019. e-Pub 2019. PMID: 30821903.
Guan F, Geng C, Carlson DJ, Ma DH, Bronk L, Gates D, Wang X, Kry SF, Grosshans D, Mohan R. A mechanistic relative biological effectiveness model-based biological dose optimization for charged particle radiobiology studies. Phys Med Biol 64(1):015008, 2018. e-Pub 2018. PMID: 30523805.
Durante M, Paganetti H, Pompos A, Kry SF, Wu X, Grosshans DR. Report of a National Cancer Institute special panel: characterization of the physical parameters of particle beams for biological research. Med Phys. e-Pub 2018. PMID: 30506898.
Scarboro SB, Cody D, Stingo FC, Alvarez P, Followill D, Court L, Zhang D, McNitt-Gray M, Kry SF. Calibration strategies for use of the nanoDot OSLD in CT applications. J Appl Clin Med Phys. e-Pub 2018. PMID: 30426664.
FitzGerald TJ, Bishop-Jodoin M, Laurie F, O'Meara E, Davis C, Bogart J, Kalapurakal J, Siegel MJ, Chakravarthy B, Okunieff P, Haffty B, Michalski J, Ulin K, Followill DS, Kry S, Knopp M, Zhang J, Rosen D, Rosen M, Xiao Y, Schwartz L, Moni J, Cicchetti MG. The importance of Imaging in Radiation Oncology for national clinical trials network protocols. Int J Radiat Oncol Biol Phys 102(4):775-782, 2018. e-Pub 2018. PMID: 30353882.
Glenn MC, Hernandez V, Saez J, Followill DS, Howell RM, Pollard-Larkin JM, Zhou S, Kry SF. Treatment plan complexity does not predict IROC Houston anthropomorphic head and neck phantom performance. Phys Med Biol 63(20):205015, 2018. e-Pub 2018. PMID: 30230475.
Vassiliev ON, Kry SF, Wang HC, Peterson CB, Chang JY, Mohan R. Radiotherapy of lung cancers: FFF beams improve dose coverage at tumor periphery compromised by electronic disequilibrium. Phys Med Biol 63(19):195007, 2018. e-Pub 2018. PMID: 30189421.
Kry S, Peterson CB, Howell RM, Izewska J, Lye J, Clark CH, Nakamura M, Hurkmans C, Alvarez P, Alves A, Bokulic T, Followill D, Kazantsev P, Lowenstein J, Molineu A, Palmer J, Smith SA, Taylor P, Wesolowska P, Williams I. Remote beam output audits: A global assessment of results out of tolerance. phiRO 7:39-44, 2018. e-Pub 2018.
Kerns JR, Followill DS, Lowenstein J, Molineu A, Alvarez P, Taylor PA, Kry SF. Reference dosimetry data and modeling challenges for Elekta accelerators based on IROC-Houston site visit data. Med Phys 45(5):2337-2344, 2018. e-Pub 2018. PMID: 29537634.
Craft DF, Kry SF, Balter P, Salehpour M, Woodward W, Howell RM. Material Matters: Analysis of density uncertainty in 3D printing and its consequences for radiation oncology. Med Phys 45(4):1614-1621, 2018. e-Pub 2018. PMID: 29493803.
Vassiliev ON, Kry SF, Grosshans DR, Mohan R. Average stopping powers for electron and photon sources for radiobiological modeling and microdosimetric applications. Phys Med Biol 63(5):055007, 2018. e-Pub 2018. PMID: 29411712.
Lechner W, Wesolowska P, Azangwe G, Mehenna A, Alves VGL, Suming L, Ekendahl D, Bulski W, Samper JLA, Vinatha SP, Siri S, Tomsej M, Tenhunen M, Povall J, Kry S, Followill D, Thwaites DI, Georg D, Izewska J. A multinational audit of small field output factors calculated by treatment planning systems used in radiotherapy. Physics and Imaging on Radiation Oncology 5:58-63, 2018. e-Pub 2018.
Lewis DJ, Taylor PA, Followill DS, Sahoo N, Mahajan A, Stingo FC, Kry SF. A new anthropomorphic pediatric spine phantom for proton therapy clinical trial credentialing. Int J Part Ther 4(4):20-27, 2018. e-Pub 2018. PMID: 30214913.
Kry SF, Dromgoole L, Alvarez P, Leif J, Molineu A, Taylor P, Followill DS. Radiation therapy deficiencies identified during on-site dosimetry visits by the Imaging and Radiation Oncology Core Houston quality assurance center. Int J Radiat Oncol Biol Phys 99(5):1094-1100, 2017. e-Pub 2017. PMID: 29029890.
Hussein M, Clementel E, Eaton DJ, Greer PB, Haworth A, Ishikura S, Kry SF, Lehmann J, Lye J, Monti AF, Nakamura M, Hurkmans C, Clark CH. A virtual dosimetry audit - towards transferability of gamma index analysis between clinical trial QA groups. Radiother Oncol 125(3):398-404, 2017. e-Pub 2017. PMID: 29100698.
Faught JT, Balter PA, Johnson JL, Kry SF, Court LE, Stingo FC, Followill DS. An FMEA evaluation of intensity modulated radiation therapy dose delivery failures at tolerance criteria levels. Med Phys 44(11):5575-5583, 2017. e-Pub 2017. PMID: 28862765.
Alvarez P, Kry SF, Stingo F, Followill D. TLD and OSLD dosimetry systems for remote audits of radiotherapy external beam calibration. Radiat Meas 106(106):412-415, 2017. e-Pub 2017. PMID: 29230093.
Kry SF, Bednarz B, Howell RM, Dauer L, Followill D, Klein E, Paganetti H, Wang B, Wuu CS, George Xu X. AAPM TG 158: Measurement and calculation of doses outside the treated volume from external-beam radiation therapy. Med Phys 44(10):e391-e429, 2017. e-Pub 2017. PMID: 28688159.
Faught AM, Davidson SE, Popple R, Kry SF, Etzel C, Ibbott GS, Followill DS. Development of a flattening filter free multiple source model for use as an independent, Monte Carlo, dose calculation, quality assurance tool for clinical trials. Med Phys 44(9):4952-4960, 2017. e-Pub 2017. PMID: 28657114.
Faught AM, Davidson SE, Fontenot J, Kry SF, Etzel C, Ibbott GS, Followill DS. Development of a Monte Carlo multiple source model for inclusion in a dose calculation auditing tool. Med Phys 44(9):4943-4951, 2017. e-Pub 2017. PMID: 28640950.
Kerns JR, Stingo F, Followill DS, Howell RM, Melancon A, Kry SF. Treatment planning system calculation errors are present in most Imaging and Radiation Oncology Core-Houston phantom failures. Int J Radiat Oncol Biol Phys 98(5):1197-1203, 2017. e-Pub 2017. PMID: 28721904.
Taylor PA, Kry SF, Followill DS. Pencil beam algorithms are unsuitable for proton dose calculations in lung. Int J Radiat Oncol Biol Phys. e-Pub 2017. PMID: 28843371.
Mell LK, Sirák I, Wei L, Tarnawski R, Mahantshetty U, Yashar CM, McHale MT, Xu R, Honerkamp-Smith G, Carmona R, Wright M, Williamson CW, Kasaová L, Li N, Kry S, Michalski J, Bosch W, Straube W, Schwarz J, Lowenstein J, Jiang SB, Saenz CC, Plaxe S, Einck J, Khorprasert C, Koonings P, Harrison T, Shi M, Mundt AJ. Bone marrow-sparing intensity modulated radiation therapy with concurrent cisplatin for stage IB-IVA cervical cancer: An international multicenter phase II clinical trial (INTERTECC-2). Int J Radiat Oncol Biol Phys 97(3):536-545, 2017. e-Pub 2017. PMID: 28126303.
Carson ME, Molineu A, Taylor PA, Followill DS, Stingo FC, Kry SF. Examining credentialing criteria and poor performance indicators for IROC Houston's anthropomorphic head and neck phantom. Med Phys 43(12):6491, 2016. e-Pub 2016. PMID: 27908168.
Huang JY, Followill DS, Howell RM, Liu X, Mirkovic D, Stingo FC, Kry SF. Approaches to reducing photon dose calculation errors near metal implants. Med Phys 43(9):5117, 2016. e-Pub 2016. PMID: 27587042.
Gladstone DJ, Kry SF, Xiao Y, Chetty IJ. Dose Specification for NRG Radiation Therapy Trials. Int J Radiat Oncol Biol Phys 95(5):1344-1345, 2016. e-Pub 2016. PMID: 27479721.
Kerns JR, Followill DS, Lowenstein J, Molineu A, Alvarez P, Taylor PA, Kry SF. Agreement between institutional measurements and treatment planning system calculations for basic dosimetric parameters as measured by the Imaging and Radiation Oncology Core-Houston. Int J Radiat Oncol Biol Phys 95(5):1527-1534, 2016. e-Pub 2016. PMID: 27315667.
Cardenas CE, Nitsch PL, Kudchadker RJ, Howell RM, Kry SF. Out-of-field doses and neutron dose equivalents for electron beams from modern Varian and Elekta linear accelerators. J Appl Clin Med Phys 17(4):442-455, 2016. e-Pub 2016. PMID: 27455499.
Taylor PA, Kry SF, Alvarez P, Keith T, Lujano C, Hernandez N, Followill DS. Results from the Imaging and Radiation Oncology Core Houston's anthropomorphic phantoms used for proton therapy clinical trial credentialing. Int J Radiat Oncol Biol Phys 95(1):242-248, 2016. e-Pub 2016. PMID: 27084644.
Hunter LA, Chen YP, Zhang L, Matney JE, Choi H, Kry SF, Martel MK, Stingo F, Liao Z, Gomez D, Yang J, Court LE. NSCLC tumor shrinkage prediction using quantitative image features. Comput Med Imaging Graph 49:29-36, 2016. e-Pub 2016. PMID: 26878137.
Davidson SE, Cui J, Kry S, Deasy JO, Ibbott GS, Vicic M, White RA, Followill DS. Modification and validation of an analytical source model for external beam radiotherapy Monte Carlo dose calculations. Med Phys 43(8):4842, 2016. e-Pub 2016. PMID: 27487902.
Kerns JR, Followill DS, Lowenstein J, Molineu A, Alvarez P, Taylor PA, Stingo FC, Kry SF. Technical Report: reference photon dosimetry data for Varian accelerators based on IROC-Houston site visit data. Med Phys 43(5):2374, 2016. e-Pub 2016. PMID: 27147349.
Smilowitz JB, Das IJ, Feygelman V, Fraass BA, Kry SF, Marshall IR, Mihailidis DN, Ouhib Z, Ritter T, Snyder MG, Fairobent L. AAPM Medical Physics Practice Guideline 5.a.: Commissioning and QA of treatment planning dose calculations - megavoltage photon and electron beams. J Appl Clin Med Phys 16(5):14–34, 2015. e-Pub 2015. PMID: 26699330.
Grant JD, Jensen GL, Tang C, Pollard JM, Kry SF, Krishnan S, Dougherty AH, Gomez DR, Rozner MA. Radiotherapy-induced malfunction in contemporary cardiovascular implantable electronic devices-clinical incidence and predictors. JAMA Oncol 9(1):1787, 2015. e-Pub 2015. PMID: 26181143.
Xiao Y, Kry SF, Popple R, Yorke E, Papanikolaou N, Stathakis S, Xia P, Huq S, Bayouth J, Galvin J, Yin FF. Flattening filter-free accelerators: a report from the AAPM Therapy Emerging Technology Assessment Work Group. J Appl Clin Med Phys 16(3):12-29, 2015. e-Pub 2015. PMID: 26103482.
Scarboro SB, Cody D, Alvarez P, Followill D, Court L, Stingo FC, Zhang D, McNitt-Gray M, Kry SF. Characterization of the nanoDot OSLD dosimeter in CT. Med Phys 42(4):1797-1807, 2015. e-Pub 2015. PMID: 25832070.
Huang JY, Kerns JR, Nute JL, Liu X, Balter PA, Stingo FC, Followill DS, Mirkovic D, Howell RM, Kry SF. An evaluation of three commercially available metal artifact reduction methods for CT imaging. Phys Med Biol 60(3):1047-1067, 2015. e-Pub 2015. PMID: 25585685.
McKenzie EM, Balter PA, Stingo FC, Jones J, Followill DS, Kry SF. Toward optimizing patient-specific IMRT QA techniques in the accurate detection of dosimetrically acceptable and unacceptable patient plans. Med Phys 41(12):121702, 2014. e-Pub 2014. PMID: 25471949.
Yu J, Straube W, Mayo C, Giaddui T, Bosch W, Ulin K, Kry SF, Galvin J, Xiao Y. Radiation therapy digital data submission process for national clinical trials network. Int J Radiat Oncol Biol Phys 90(2):466-7, 2014. e-Pub 2014. PMID: 25304799.
Kry SF, Molineu A, Kerns JR, Faught AM, Huang JY, Pulliam KB, Tonigan J, Alvarez P, Stingo F, Followill DS. Institutional patient-specific IMRT QA does not predict unacceptable plan delivery. Int J Radiat Oncol Biol Phys 90(5):1195-1201. e-Pub 2014. PMID: 25442044.
Kerns JR, Childress N, Kry SF. A multi-institution evaluation of MLC log files and performance in IMRT delivery. Radiat Oncol 9:176, 2014. e-Pub 2014. PMID: 25112533.
Huang JY, Pulliam KB, McKenzie EM, Followill DS, Kry SF. Effects of spatial resolution and noise on gamma analysis for IMRT QA. J Appl Clin Med Phys 15(4):4690, 2014. e-Pub 2014. PMID: 25207399.
Pulliam KB, Huang JY, Howell RM, Followill D, Bosca R, O'Daniel J, Kry SF. Comparison of 2D and 3D gamma analyses. Med Phys 41(2):021710, 2014. e-Pub 2014. PMID: 24506601.
McKenzie EM, Balter PA, Stingo FC, Jones J, Followill DS, Kry SF. Reproducibility in patient-specific IMRT QA. J Appl Clin Med Phys 15(3):4741, 2014. e-Pub 2014. PMID: 24892350.
Pulliam KB, Followill D, Court L, Dong L, Gillin M, Prado K, Kry SF. A six-year review of more than 13,000 patient-specific IMRT QA results from 13 different treatment sites. J Appl Clin Med Phys 15(5):196-206, 2014. e-Pub 2014. PMID: 25207581.
Huang JY, Eklund D, Childress NL, Howell RM, Mirkovic D, Followill DS, Kry SF. Investigation of various energy deposition kernel refinements for the convolution superposition method. Med Phys 40(12):121721, 2013. e-Pub 2013. PMID: 24320507.
Hunter LA, Kraft S, Stingo F, Choi H, Martel MK, Kry SF, Court LE. High quality machine-robust image features: identification in non-small cell lung cancer computed tomography images. Med Phys 40(121):916, 2013. e-Pub 2013. PMID: 24320527.
Casey KE, Alvarez P, Kry SF, Howell RM, Lawyer A, Followill D. Development and implementation of a remote audit tool for high dose rate (HDR) Ir-192 brachytherapy using optically stimulated luminescence dosimetry. Med Phys 40(11):2102, 2013. e-Pub 2013. PMID: 24320455.
Faught AM, Kry SF, Luo D, Molineu A, Bellezza D, Gerber RL, Davidson SE, Bosch W, Drzymala RE, Galvin J, Timmerman R, Sheehan J, Gillin MT, Ibbott GS, Followill DS. Development of a modified head and neck quality assurance phantom for use in stereotactic radiosurgery trials. J Appl Clin Med Phys 14(4):206-215, 2013. e-Pub 2013. PMID: 23835394.
Court LE, Tucker SL, Gomez D, Liao Z, Zhang J, Kry S, Dong L, Martel MK. A technique to use CT images for in vivo detection and quantification of the spatial distribution of radiation-induced esophagitis. J Appl Clin Med Phys 14(3):4195, 2013. e-Pub 2013. PMID: 23652249.
Huang JY, Followill DS, Wang XA, Kry SF. Accuracy and sources of error of out-of field dose calculations by a commercial treatment planning system for intensity modulated radiation therapy treatments. J Appl Clin Med Phys 14(2):4139, 2013. e-Pub 2013. PMID: 23470942.
Kry SF, Alvarez P, Molineu A, Amador C, Galvin J, Followill DS. Algorithms used in heterogeneous dose calculations show systematic differences as measured with the Radiological Physics Center's anthropomorphic thorax phantom used for RTOG credentialing. Int J Radiat Oncol Biol Phys 85(1):e95-100, 2013. e-Pub 2013. PMID: 23237006.
Scarboro SB, Kry SF. Characterisation of energy response of Al(2)O(3):C optically stimulated luminescent dosemeters (OSLDs) using cavity theory. Radiat Prot Dosimetry 153(1):23-31, 2013. e-Pub 2013. PMID: 22653437.
Hälg RA, Besserer J, Boschung M, Mayer S, Clasie B, Kry SF, Schneider U. Field calibration of PADC track etch detectors for local neutron dosimetry in man using different radiation qualities. Nuclear Instruments and Methods in Physics Research 694:205-210, 2012. e-Pub 2012.
Kry SF, Popple R, Molineu A, Followill DS. Ion recombination correction factors (Pion) for Varian TrueBeam high-dose-rate therapy beams. J Appl Clin Med Phys 13(6):3803, 2012. e-Pub 2012. PMID: 23149774.
Kry SF, Jones J, Childress NL. Implementation and evaluation of an end-to-end IGRT test. J Appl Clin Med Phys 13(5):3939, 2012. e-Pub 2012. PMID: 22955659.
Watt TC, Inskip PD, Stratton K, Smith SA, Kry SF, Sigurdson AJ, Stovall M, Leisenring W, Robison LL, Mertens AC. Radiation-related risk of basal cell carcinoma: a report from the Childhood Cancer Survivor Study. J Natl Cancer Inst 104(16):1240-1250, 2012. e-Pub 2012. PMID: 22835387.
Followill DS, Kry SF, Qin L, Lowenstein J, Molineu A, Alvarez P, Aguirre JF, Ibbott GS. The Radiological Physics Center's standard dataset for small field size output factors. J Appl Clin Med Phys 13(5):3962, 2012. e-Pub 2012. PMID: 22955664.
Kry SF, Smith SA, Weathers R, Stovall M. Skin dose during radiotherapy: a summary and general estimation technique. J Appl Clin Med Phys 13(3):3734, 2012. e-Pub 2012. PMID: 22584171.
Scarboro SB, Followill DS, Kerns JR, White RA, Kry SF. Energy response of optically stimulated luminescent dosimeters for non-reference measurement locations in a 6 MV photon beam. Phys Med Biol 57(9):2505-2515, 2012. e-Pub 2012. PMID: 22493180.
Kerns JR, Kry SF, Sahoo N. Characteristics of optically stimulated luminescence dosimeters in the spread-out Bragg peak region of clinical proton beams. Med Phys 39(4):1854-1863, 2012. e-Pub 2012. PMID: 22482607.
Joy S, Starkschall G, Kry S, Salehpour M, White RA, Lin SH, Balter P. Dosimetric effects of jaw tracking in step-and-shoot intensity-modulated radiation therapy. J Appl Clin Med Phys 13(2):3707, 2012. e-Pub 2012. PMID: 22402386.
Neubauer E, Dong L, Followill DS, Garden AS, Court LE, White RA, Kry SF. Assessment of shoulder position variation and its impact on IMRT and VMAT doses for head and neck cancer. Radiat Oncol 7(19), 2012. e-Pub 2012. PMID: 22316381.
Pulliam KB, Howell RM, Followill D, Luo D, White RA, Kry SF. The clinical impact of the couch top and rails on IMRT and arc therapy. Phys Med Biol 56(23):7435-7447, 2011. e-Pub 2011. PMID: 22056949.
Howell RM, Kry SF, Burgett E, Hertel NE, Followill D. Erratum: Secondary neutron spectra from modern Varian, Siemens, and Elekta linacs with multileaf collimators [Med. Phys. 36(9), 4027-4038 (2009)]. Med Phys 38(12):6789, 2011. e-Pub 2011. PMID: 28525097.
Beyer GP, Kry SF, Espenhahn E, Rini C, Boyles E, Mann G. Evaluation of an implantable MOSFET dosimeter designed for use with hypo-fractionated external beam treatments and its applications for breast and prostate treatments. Med Phys 38(8):4881-4887, 2011. e-Pub 2011. PMID: 21928659.
Kerns JR, Kry SF, Sahoo N, Followill DS, Ibbott GS. Angular dependence of the nanoDot OSL dosimeter. Med Phys 38(7):3955-3962, 2011. e-Pub 2011. PMID: 21858992.
Scarboro SB, Followill DS, Howell RM, Kry SF. Variations in photon energy spectra of a 6 MV beam and their impact on TLD response. Med Phys 38(5):2619-2628, 2011. e-Pub 2011. PMID: 21776799.
Berrington de Gonzalez A, Curtis RE, Kry SF, Gilbert E, Lamart S, Berg CD, Stovall M, Ron E. Proportion of second cancers attributable to radiotherapy treatment in adults: a cohort study in the US SEER cancer registries. Lancet Oncol 12(4):353-360, 2011. e-Pub 2011. PMID: 21454129.
Kry SF, Johnson JL, White RA, Howell RM, Kudchadker RJ, Gillin MT. Neutron-induced electronic failures around a high-energy linear accelerator. Med Phys 38(1):34-39, 2011. e-Pub 2011. PMID: 21361172.
Scarboro SB, Stovall M, White A, Smith SA, Yaldo D, Kry SF, Howell RM. Effect of organ size and position on out-of-field dose distributions during radiation therapy. Phys Med Biol 55(23):7025-7036, 2010. e-Pub 2010. PMID: 21076195.
Howell RM, Scarboro SB, Taddei PJ, Krishnan S, Kry SF, Newhauser WD. Methodology for determining doses to in-field, out-of-field and partially in-field organs for late effects studies in photon radiotherapy. Phys Med Biol 55(23):7009-7023, 2010. e-Pub 2010. PMID: 21076193.
Howell RM, Scarboro SB, Kry SF, Yaldo DZ. Accuracy of out-of-field dose calculations by a commercial treatment planning system. Phys Med Biol 55(23):6999-7008, 2010. e-Pub 2010. PMID: 21076191.
Serago CF, Burmeister JW, Dunscombe PB, Gale AA, Hendee WR, Kry SF, Wuu CS. Recommended ethics curriculum for medical physics graduate and residency programs: Report of Task Group 159. Med Phys 37(8):4495-4500, 2010. e-Pub 2010. PMID: 20879608.
Wang Z, Howell RM, Burgett EA, Kry SF, Hertel NE, Salehpour M. Calibration of indium response functions in an Au-In-BSE system up to 800 MeV. Radiat Prot Dosimetry 139(4):565-573, 2010. e-Pub 2010. PMID: 20008907.
Kry SF, Vassiliev ON, Mohan R. Out-of-field photon dose following removal of the flattening filter from a medical accelerator. Phys Med Biol 55(8):2155-2166, 2010. e-Pub 2010. PMID: 20305334.
Price MJ, Kry SF, Eifel PJ, Salehpour M, Mourtada F. Dose perturbation due to the polysulfone cap surrounding a Fletcher-Williamson colpostat. J Appl Clin Med Phys 11(1):3146, 2010. e-Pub 2010. PMID: 20160700.
Wang Z, Howell RM, Kry SF, Burgett EA, Hertel NE, Salehpour MN. Characterization of a gold-and-indium dual-activation-foil-based Bonner Sphere System. Nuclear Technology 168(3):603-609, 2009. e-Pub 2009.
Howell RM, Burgett E, Hertel NE, Kry SF, Wang Z, Salehpour M. Measurement of high-energy neutron spectra with Bonner extension system. Nuclear Technology 168(2):333-339, 2009. e-Pub 2009.
Johnson J, Nelson R, Hickman V, Kry SF. The cover up: skin dose increase during external beam therapy. Radiation Therapist 18(7):97, 2009. e-Pub 2009.
Howell RM, Kry SF, Burgett E, Followill D, Hertel NE. Effects of tertiary MLC configuration on secondary neutron spectra from 18-MV x-ray beams for the Varian 21 EX linear accelerator. Med Phys 36(9):4039-4046, 2009. e-Pub 2009. PMID: 19810476.
Howell RM, Kry SF, Burgett E, Hertel NE, Followill DS. Secondary neutron spectra from modern Varian, Siemens, and Elekta linacs with multileaf collimators. Med Phys 36(9):4027-4038, 2009. e-Pub 2009. PMID: 19810475.
Kry SF, Salehpour M, Titt U, White RA, Stovall M, Followill D. Monte Carlo study shows no significant difference in second cancer risk between 6- and 18-MV intensity-modulated radiation therapy. Radiother Oncol 91(1):132-137, 2009. e-Pub 2009. PMID: 19147246.
Kry SF, Howell RM, Salehpour M, Followill DS. Neutron spectra and dose equivalents calculated in tissue for high-energy radiation therapy. Med Phys 36(4):1244-1250, 2009. e-Pub 2009. PMID: 19472632.
Kry SF, Howell RM, Polf J, Mohan R, Vassiliev ON. Treatment vault shielding for a flattening filter free medical linear accelerator. Phys Med Biol 54(5):1265-1273, 2009. e-Pub 2009. PMID: 19190359.
Kry SF, Price M, Wang Z, Mourtada F, Salehpour M. Investigation into the use of a MOSFET dosimeter as an implantable fiducial marker. J Appl Clin Med Phys 10(1):2893, 2009. e-Pub 2009. PMID: 19223838.
Vassiliev ON, Kry SF, Chang JY, Balter PA, Titt U, Mohan R. Stereotactic radiotherapy for lung cancer using a flattening filter free Clinac. J Appl Clin Med Phys 10(1):2880, 2009. e-Pub 2009. PMID: 19223837.
Wang Z, Kry SF, Howell RM, Salehpour M. Comparison of unfolding methods for determining neutron spectrum and ambient dose equivalent. Nuclear Technology 168(3):610-614, 2009. e-Pub 2009.
Kry SF, Howell RM, Titt U, Salehpour M, Mohan R, Vassiliev ON. Energy spectra, sources, and shielding considerations for neutrons generated by a flattening filter-free clinac. Med Phys 35(5):1906-1911, 2008. e-Pub 2008. PMID: 18561666.
Kry SF, Price MJ, Followill D, Mourtada F, Salehpour M. The use of LiF (TLD-100) as an out-of field dosimeter. J Appl Clin Med Phys 8(4):169-175, 2007. e-Pub 2007. PMID: 18449155.
Kry SF, Titt U, Followill D, Pönisch F, Vassiliev ON, White RA, Stovall M, Salehpour M. A Monte Carlo model for out-of-field dose calculation from high-energy photon therapy. Med Phys 34(9):3489-3499, 2007. e-Pub 2007. PMID: 17926952.
Vassiliev ON, Kry SF, Kuban DA, Salehpour M, Mohan R, Titt U. Treatment-planning study of prostate cancer intensity-modulated radiotherapy with a Varian Clinac operated without a flattening filter. Int J Radiat Oncol Biol Phys 68(5):1567-71, 2007. e-Pub 2007. PMID: 17544596.
Kry SF, Titt U, Poenisch F, Vassiliev ON, Salehpour M, Gillin M, Mohan R. Reduced neutron production through use of a flattening filter free accelerator. Int J Radiat Oncol Biol Phys 68(4):1260-1264, 2007. e-Pub 2007. PMID: 17637397.
Kry SF, Followill D, White RA, Stovall M, Kuban DA, Salehpour M. Uncertainty of calculated risk estimates for secondary malignancies after radiotherapy. Int J Radiat Oncol Biol Phys 68(4):1265-71, 2007. e-Pub 2007. PMID: 17637398.
Kry SF, Starkschall G, Antolak JA, Salehpour M. Evaluation of the accuracy of fetal dose estimates using TG-36 data. Med Phys 34(4):1193-1197, 2007. e-Pub 2007. PMID: 17500450.
Vassiliev ON, Titt U, Kry SF, Mohan R, Gillin MT. Radiation safety survey on a flattening filter-free medical accelerator. Radiat Prot Dosimetry 124(2):187-190, 2007. e-Pub 2007. PMID: 17681966.
Kry SF, Titt U, Pönisch F, Followill D, Vassiliev ON, White RA, Mohan R, Salehpour M. A Monte Carlo model for calculating out-of-field dose from a Varian 6 MV beam. Med Phys 33(11):4405-4413, 2006. e-Pub 2006. PMID: 17153419.
Titt U, Vassiliev ON, Ponisch F, Kry SF, Mohan R. Monte Carlo study of backscatter in a flattening filter free clinical accelerator. Med Phys 33(9):3270-3273, 2006. e-Pub 2006. PMID: 17022221.
Vassiliev ON, Titt U, Poenisch F, Kry SF, Mohan R, Gillin MT. Dosimetric properties of photon beams from a flattening filter free clinical accelerator. Phys Med Biol 51(7):1907-1917, 2006. e-Pub 2006. PMID: 16552113.
Ponisch F, Titt U, Vassiliev ON, Kry SF, Mohan R. Properties of unflattened photon beams shaped by a multi leaf collimator. Med Phys 33(6):1738-1746, 2006. e-Pub 2006. PMID: 16872081.
Vassiliev ON, Titt U, Kry SF, Ponisch F, Gillin MT, Mohan R. Monte Carlo study of photon fields from a flattening filter free clinical accelerator. Med Phys 33(4):820-827, 2006. e-Pub 2006. PMID: 16696457.
Ponisch F, Titt U, Kry SF, Vassiliev ON. MCNPX simulation of a multileaf collimator. Med Phys 33(2):402-404, 2006. e-Pub 2006. PMID: 16532947.
Kry SF, Salehpour M, Followill DS, Stovall M, Kuban DA, White RA, Rosen II. The calculated risk of fatal secondary malignancies from intensity-modulated radiation therapy. Int J Radiat Oncol Biol Phys 62(4):1195-1203, 2005. e-Pub 2005. PMID: 15990025.
Kry SF, Salehpour M, Followill D, Stovall M, Kuban D, White RA, Rose I. Out-of-field photon and neutron dose equivalents from step and shoot intensity modulated radiation therapy. Int J Radiat Oncol Biol Phys 62(4):1204-1216, 2005. e-Pub 2005. PMID: 15990026.
Followill D, Stovall M, Kry SF, Ibbott G. Neutron source strength measurements for Varian, Siemens, Elekta, and General Electric linear accelerators. J Appl Clin Med Phys 4(3):189-194, 2003. e-Pub 2003. PMID: 12841788.
Suprunowicz R, Butler RM, Ford COK, Kry SF. An experimental investigation of convergent flow to horizontal wells. Journal of Canadian Petroleum Technology 37(10):51-57, 1998. e-Pub 1998.

Review Articles

Xiao, Y, Benedict, SH, Cui, Y, Glide-Hurst, CK, Graves, S, Jia, X, Kry, SF, Li, H, Lin, L, Matuszak, MM, Newpower, M, Paganetti, H, Qi, XS, Roncali, E, Rong, Y, Sgouros, G, Simone, C, Sunderland, J, Taylor, PA, Tchelebi, LT, Weldon, M, Zou, JW, Wuthrick, EJ, Machtay, M, Le, QT, Buchsbaum, J. Embracing the Future of Clinical Trials in Radiation Therapy. International Journal of Radiation Oncology Biology Physics 122(2):443-457, 2025. e-Pub 2025. PMID: 39848295.
Fitzgerald, TJ, Bishop-Jodoin, M, Laurie, F, Iandoli, M, Smith, K, Ulin, K, Ding, L, Moni, J, Cicchetti, MG, Knopp, MV, Kry, SF, Xiao, Y, Rosen, M, Prior, F, Saltz, J, Michalski, J. The Importance of Quality Assurance in Radiation Oncology Clinical Trials. Seminars in radiation oncology 33(4):395-406, 2023. e-Pub 2023. PMID: 37684069.
Zou W, Zhang R, Schüler E, Taylor PA, Mascia AE, Diffenderfer ES, Zhao T, Ayan AS, Sharma M, Yu SJ, Lu W, Bosch WR, Tsien C, Surucu M, Pollard-Larkin JM, Schuemann J, Moros EG, Bazalova-Carter M, Gladstone DJ, Li H, Simone CB, Petersson K, Kry SF, Maity A, Loo BW, Dong L, Maxim PG, Xiao Y, Buchsbaum JC. Framework for Quality Assurance of Ultrahigh Dose Rate Clinical Trials Investigating FLASH Effects and Current Technology Gaps. Int J Radiat Oncol Biol Phys 116(5):1202-1217, 2023. e-Pub 2023. PMID: 37121362.
Smith, K, Ulin, K, Knopp, MV, Kry, SF, Xiao, Y, Rosen, M, Michalski, J, Iandoli, M, Laurie, F, Quigley, J, Reifler, H, Santiago, J, Briggs, K, Kirby, S, Schmitter, K, Prior, F, Saltz, J, Sharma, A, Bishop-Jodoin, M, Moni, J, Cicchetti, MG, Fitzgerald, TJ. Quality improvements in radiation oncology clinical trials. Frontiers in Oncology 13, 2023. e-Pub 2023. PMID: 36776318.
Krittanawong C, Singh NK, Scheuring RA, Urquieta E, Bershad EM, Macaulay TR, Kaplin S, Dunn C, Kry SF, Russomano T, Shepanek M, Stowe RP, Kirkpatrick AW, Broderick TJ, Sibonga JD, Lee AG, Crucian BE. Human Health during Space Travel: State-of-the-Art Review. Cells 12(1):40, 2023. e-Pub 2023. PMID: 36611835.
Zhu TC, Stathakis S, Clark JR, Feng W, Georg D, Holmes SM, Kry SF, Ma CC, Miften M, Mihailidis D, Moran JM, Papanikolaou N, Poppe B, Xiao Y. Report of AAPM Task Group 219 on independent calculation-based dose/MU verification for IMRT. Med Phys 48(10):e808-e829, 2021. e-Pub 2021. PMID: 34213772.
Kry SF, Lye J, Clark CH, Andratschke N, Dimitriadis A, Followill D, Howell R, Hussein M, Ishikawa M, Kito S, Kron T, Lee J, Michalski J, Filippo Monti A, Reynaert N, Taylor P, Venables K, Xiao Y, Lehmann J. Report dose-to-medium in clinical trials where available; a consensus from the global Harmonisation group to maximize consistency. Radiother Oncol 159:106-111, 2021. e-Pub 2021. PMID: 33741471.
Pollard-Larkin JM, Briere TM, Kudchadker RJ, Sadagopan R, Nitsch PL, Wang XA, Salehpour M, Wang J, Vedam S, Nelson CL, Sahoo N, Zhu XR, Court LE, Balter PA, Robinson IJ, Yang J, Howell RM, Followill DS, Kry S, Beddar SA, Martel MK. Our experience leading a large medical physics practice during the COVID-19 pandemic. Adv Radiat Oncol 6(4):100683, 2021. e-Pub 2021. PMID: 33824935.
Haas-Kogan D, Indelicato D, Paganetti H, Esiashvili N, Mahajan A, Yock T, Flampouri S, MacDonald S, Fouladi M, Kry S, Kalapurakal J, Terezakis S, Kooy H, Grosshans D, Makrigiorgos M, Mishra K, Poussaint TY, Cohen K, Fitzgerald T, Gondi V, Liu A, Michalski J, Mirkovic D, Mohan R, Perkins S, Wong K, Vikram B, Buchsbaum J, Kun L. National Cancer Institute workshop on proton therapy for children: considerations regarding brainstem injury. Int J Radiat Oncol Biol Phys 101(1):152-168, 2018. e-Pub 2018. PMID: 29619963.
Clark CH, Hurkmans CW, Kry SF. The role of dosimetry audit in lung SBRT multi-centre clinical trials. Phys Med 44:171-176, 2017. e-Pub 2017. PMID: 28391958.

Editorials

Howell RM, Kry SF. Invited commentary: Breast Disease: A year book quarterly. Commentary on: Inskip et al., Radiation dose and breast cancer risk in the childhood cancer survivor study. J Clin Oncol 27:3901-3907, 2009.
Kry SF, Howell RM. Invited commentary: Breast Disease: A year book quarterly. commentary on: Berrington de Gonzalez et al., Second solid cancers after radiotherapy for breast cancer in SEER cancer registries. Br J Cancer 102:220-226, 2009.
Howell RM, Kry SF, Stovall M. Invited commentary: Breast Disease: A year book quarterly. Commentary on: Yadav et al., Nonbreast second malignancies after treatment of primary breast cancer. Int J Radiat Oncol Biol Phys 73:1489-1492, 2009.
Kry SF, Howell RM. Invited commentary: Breast Disease: A year book quarterly. Commentary on: Mery et al., Second sarcomas after radiotherapy for breast cancer: sustained risk and poor survival. Cancer 115:4055-4063, 2009.

Abstracts

Howell RM, Kry SF, Garden A, Mohan R. Investigation of volumetric arc therapy for therapy for head and neck cancer. Int J Radiat Oncol Biol Phys 72:S24, 2008. e-Pub 2008.
Kry SF, Vassiliev ON, Kuban D, Poenisch F, Salehpour M, Gillin MT, Mohan R. Prostate IMRT using unflattened beams. Int J Radiat Oncol Biol Phys 66(3):S78, 2006. e-Pub 2006.
Kry SF, Salehpour M, Followill D, Stovall M, Kuban DA, White RA, Rose I. Risk assessment of secondary malignancies from IMRT treatments. Int J Radiat Oncol Biol Phys 60(1):S354-355, 2004. e-Pub 2004.

Book Chapters

FitzGerald TJ, Laurie F, Iandoli M, Bishop-Jodoin M, Smith K, Ulin K, Moni J, Cicchetti M, Kry SF, Knopp M, Xiao Y, Rosen M, Prior F, Saltz J. Modern Clinical Trials in Radiation Oncology, 2022.
Lye J, Kry SF, Lehmann J. Dosimetric considerations with flattening filter free beams. In: In: Radiation Therapy Dosimetry, a pratical handbook. Taylor and Frances Books, 2021.
Kry SF, O'Daniel J. Optically stimulated luminescent dosimeters in clinical practice. In: In: Radiation Therapy Dosimetry, a pratical handbook. Taylor and Frances Books, 2021.
DeWerd L, Hammer C, Kry SF. Medical applications of luminescent materials. In: Advances in Physics and Applications of Optically and Thermally Stimulated Luminescence. World Scientific Publishing, 2019.
Kry SF, Howell RM, Bednarz B. Dose outside the treatment volume in external beam therapy. In: Clinical 3D Dosimetry in Modern Radiation Therapy. Taylor and Francis Group, 2017.
Xiao Y, Kry SF, Followill DS. Quality assurance and safety requirements for clinical trials. In: Quality and Safety in Radiation Oncology. Spring Publishing, 2017.
Benedict SH, Goetsch S, Perks J, Wijesooriya K, Mifton M, Vinogradskiy Y, Medin P, Desovich Y, Lovelock MD, Low DA, Kry SF. Stereotactic radiation therapy. In: Radiation Therapy Physics. Elsevier Ltd, 2014.
Howell RM, Kry SF. Modulated arc therapy planning. In: Radiation Therapy Physics. Elsevier Ltd, 2014.
Biggs P, Kry SF. Monte Carlo for shielding of radiotherapy facilities. In: Monte Carlo Techniques in Radiation Therapy. Taylor & Francis Group, 2013.

Letters to the Editor

Kry SF, Olch A, Mohan R. Comment on “Monte Carlo evaluations of the absorbed dose and quality dependence of Al2O3 in radiotherapy photon beams”. Med Phys 42: 2648-2649.
Followill DS, Kry SF. Response to Thomsen et al: comments on "The Radiological Physics Center's standard dataset for small field size output factors". J Appl Clin Med Phys 15: 4841.
Kry SF, Salehpour M. In response to Dr. Schneider. Int J Radiat Oncol Biol Phys 64: 1290-1291, 2006.

Less

CV information above last modified March 26, 2026

Stephen F. Kry, Ph.D.

About Dr. Stephen F. Kry

Present Title & Affiliation

Primary Appointment

Dual/Joint/Adjunct Appointment

Education & Training

Degree-Granting Education

Licenses & Certifications

Experience & Service

Faculty Academic Appointments

Administrative Appointments/Responsibilities

Other Professional Positions

Extramural Institutional Committee Activities

Editorial Activities

Honors & Awards

Professional Memberships

Selected Presentations & Talks

Local Presentations

National Presentations

International Presentations

Formal Peers

Grant & Contract Support

Selected Publications

Peer-Reviewed Articles

Review Articles

Other Articles

Editorials

Abstracts

Book Chapters

Letters to the Editor

Patient Reviews

Related Links

Care Centers and Clinics

Departments and Divisions

Labs

Help #EndCancer

Stephen F. Kry, Ph.D.

About Dr. Stephen F. Kry

Present Title & Affiliation

Primary Appointment

Dual/Joint/Adjunct Appointment

Education & Training

Degree-Granting Education

Licenses & Certifications

Experience & Service

Faculty Academic Appointments

Administrative Appointments/Responsibilities

Other Professional Positions

Extramural Institutional Committee Activities

Editorial Activities

Honors & Awards

Professional Memberships

Selected Presentations & Talks

Local Presentations

National Presentations

International Presentations

Formal Peers

Grant & Contract Support

Selected Publications

Peer-Reviewed Articles

Review Articles

Other Articles

Editorials

Abstracts

Book Chapters

Letters to the Editor

Patient Reviews

Request an Appointment

Related Links

Care Centers and Clinics

Departments and Divisions

Labs

Clinical Trials

Help #EndCancer

Give Now

Donate Blood

Shop UT MD Anderson